Many modules are hidden in this stack. Use "module --show_hidden spider SOFTWARE" if you are not able to find the required software
# packages in environment at /cluster/home/gcardenal/miniconda3/envs/vllm:
#
# Name                    Version                   Build  Channel
_libgcc_mutex             0.1                        main  
_openmp_mutex             5.1                       1_gnu  
accelerate                1.1.1                    pypi_0    pypi
aiohappyeyeballs          2.4.0                    pypi_0    pypi
aiohttp                   3.10.6                   pypi_0    pypi
aiosignal                 1.3.1                    pypi_0    pypi
annotated-types           0.7.0                    pypi_0    pypi
anthropic                 0.40.0                   pypi_0    pypi
anyio                     4.6.0                    pypi_0    pypi
argon2-cffi               23.1.0                   pypi_0    pypi
argon2-cffi-bindings      21.2.0                   pypi_0    pypi
arrow                     1.3.0                    pypi_0    pypi
asttokens                 3.0.0                    pypi_0    pypi
async-lru                 2.0.4                    pypi_0    pypi
async-timeout             4.0.3                    pypi_0    pypi
attrs                     24.2.0                   pypi_0    pypi
babel                     2.16.0                   pypi_0    pypi
beautifulsoup4            4.12.3                   pypi_0    pypi
bleach                    6.2.0                    pypi_0    pypi
bzip2                     1.0.8                h5eee18b_6  
ca-certificates           2024.7.2             h06a4308_0  
certifi                   2024.8.30                pypi_0    pypi
cffi                      1.17.1                   pypi_0    pypi
charset-normalizer        3.3.2                    pypi_0    pypi
click                     8.1.7                    pypi_0    pypi
cloudpickle               3.0.0                    pypi_0    pypi
comm                      0.2.2                    pypi_0    pypi
datasets                  3.0.1                    pypi_0    pypi
debugpy                   1.8.9                    pypi_0    pypi
decorator                 5.1.1                    pypi_0    pypi
defusedxml                0.7.1                    pypi_0    pypi
dill                      0.3.8                    pypi_0    pypi
diskcache                 5.6.3                    pypi_0    pypi
distro                    1.9.0                    pypi_0    pypi
einops                    0.8.0                    pypi_0    pypi
emoji                     2.14.0                   pypi_0    pypi
exceptiongroup            1.2.2                    pypi_0    pypi
executing                 2.1.0                    pypi_0    pypi
fastapi                   0.115.0                  pypi_0    pypi
fastjsonschema            2.21.1                   pypi_0    pypi
filelock                  3.16.1                   pypi_0    pypi
fqdn                      1.5.1                    pypi_0    pypi
frozenlist                1.4.1                    pypi_0    pypi
fsspec                    2024.6.1                 pypi_0    pypi
gguf                      0.10.0                   pypi_0    pypi
h11                       0.14.0                   pypi_0    pypi
httpcore                  1.0.5                    pypi_0    pypi
httptools                 0.6.1                    pypi_0    pypi
httpx                     0.27.2                   pypi_0    pypi
huggingface-hub           0.25.1                   pypi_0    pypi
idna                      3.10                     pypi_0    pypi
importlib-metadata        8.5.0                    pypi_0    pypi
interegular               0.3.3                    pypi_0    pypi
ipykernel                 6.29.5                   pypi_0    pypi
ipython                   8.30.0                   pypi_0    pypi
ipywidgets                8.1.5                    pypi_0    pypi
isoduration               20.11.0                  pypi_0    pypi
jedi                      0.19.2                   pypi_0    pypi
jinja2                    3.1.4                    pypi_0    pypi
jiter                     0.5.0                    pypi_0    pypi
json5                     0.10.0                   pypi_0    pypi
jsonpointer               3.0.0                    pypi_0    pypi
jsonschema                4.23.0                   pypi_0    pypi
jsonschema-specifications 2023.12.1                pypi_0    pypi
jupyter                   1.1.1                    pypi_0    pypi
jupyter-client            8.6.3                    pypi_0    pypi
jupyter-console           6.6.3                    pypi_0    pypi
jupyter-core              5.7.2                    pypi_0    pypi
jupyter-events            0.10.0                   pypi_0    pypi
jupyter-lsp               2.2.5                    pypi_0    pypi
jupyter-server            2.14.2                   pypi_0    pypi
jupyter-server-terminals  0.5.3                    pypi_0    pypi
jupyterlab                4.3.2                    pypi_0    pypi
jupyterlab-pygments       0.3.0                    pypi_0    pypi
jupyterlab-server         2.27.3                   pypi_0    pypi
jupyterlab-widgets        3.0.13                   pypi_0    pypi
lark                      1.2.2                    pypi_0    pypi
ld_impl_linux-64          2.40                 h12ee557_0  
libffi                    3.4.4                h6a678d5_1  
libgcc-ng                 11.2.0               h1234567_1  
libgomp                   11.2.0               h1234567_1  
libstdcxx-ng              11.2.0               h1234567_1  
libuuid                   1.41.5               h5eee18b_0  
llvmlite                  0.43.0                   pypi_0    pypi
lm-format-enforcer        0.10.6                   pypi_0    pypi
markupsafe                2.1.5                    pypi_0    pypi
matplotlib-inline         0.1.7                    pypi_0    pypi
mistral-common            1.4.3                    pypi_0    pypi
mistune                   3.0.2                    pypi_0    pypi
mpmath                    1.3.0                    pypi_0    pypi
msgpack                   1.1.0                    pypi_0    pypi
msgspec                   0.18.6                   pypi_0    pypi
multidict                 6.1.0                    pypi_0    pypi
multiprocess              0.70.16                  pypi_0    pypi
nbclient                  0.10.1                   pypi_0    pypi
nbconvert                 7.16.4                   pypi_0    pypi
nbformat                  5.10.4                   pypi_0    pypi
ncurses                   6.4                  h6a678d5_0  
nest-asyncio              1.6.0                    pypi_0    pypi
networkx                  3.3                      pypi_0    pypi
notebook                  7.3.1                    pypi_0    pypi
notebook-shim             0.2.4                    pypi_0    pypi
numba                     0.60.0                   pypi_0    pypi
numpy                     1.26.4                   pypi_0    pypi
nvidia-cublas-cu12        12.1.3.1                 pypi_0    pypi
nvidia-cuda-cupti-cu12    12.1.105                 pypi_0    pypi
nvidia-cuda-nvrtc-cu12    12.1.105                 pypi_0    pypi
nvidia-cuda-runtime-cu12  12.1.105                 pypi_0    pypi
nvidia-cudnn-cu12         9.1.0.70                 pypi_0    pypi
nvidia-cufft-cu12         11.0.2.54                pypi_0    pypi
nvidia-curand-cu12        10.3.2.106               pypi_0    pypi
nvidia-cusolver-cu12      11.4.5.107               pypi_0    pypi
nvidia-cusparse-cu12      12.1.0.106               pypi_0    pypi
nvidia-ml-py              12.560.30                pypi_0    pypi
nvidia-nccl-cu12          2.20.5                   pypi_0    pypi
nvidia-nvjitlink-cu12     12.6.68                  pypi_0    pypi
nvidia-nvtx-cu12          12.1.105                 pypi_0    pypi
openai                    1.48.0                   pypi_0    pypi
openssl                   3.0.15               h5eee18b_0  
outlines                  0.0.46                   pypi_0    pypi
overrides                 7.7.0                    pypi_0    pypi
packaging                 24.1                     pypi_0    pypi
pandas                    2.2.3                    pypi_0    pypi
pandocfilters             1.5.1                    pypi_0    pypi
parso                     0.8.4                    pypi_0    pypi
partial-json-parser       0.2.1.1.post4            pypi_0    pypi
pexpect                   4.9.0                    pypi_0    pypi
pillow                    10.4.0                   pypi_0    pypi
pip                       24.2            py310h06a4308_0  
platformdirs              4.3.6                    pypi_0    pypi
plotly                    5.24.1                   pypi_0    pypi
prometheus-client         0.21.0                   pypi_0    pypi
prometheus-fastapi-instrumentator 7.0.0                    pypi_0    pypi
prompt-toolkit            3.0.48                   pypi_0    pypi
protobuf                  5.28.2                   pypi_0    pypi
psutil                    6.0.0                    pypi_0    pypi
ptyprocess                0.7.0                    pypi_0    pypi
pure-eval                 0.2.3                    pypi_0    pypi
py-cpuinfo                9.0.0                    pypi_0    pypi
pyairports                2.1.1                    pypi_0    pypi
pyarrow                   17.0.0                   pypi_0    pypi
pycountry                 24.6.1                   pypi_0    pypi
pycparser                 2.22                     pypi_0    pypi
pydantic                  2.9.2                    pypi_0    pypi
pydantic-core             2.23.4                   pypi_0    pypi
pygments                  2.18.0                   pypi_0    pypi
python                    3.10.14              h955ad1f_1  
python-dateutil           2.9.0.post0              pypi_0    pypi
python-dotenv             1.0.1                    pypi_0    pypi
python-json-logger        2.0.7                    pypi_0    pypi
pytz                      2024.2                   pypi_0    pypi
pyyaml                    6.0.2                    pypi_0    pypi
pyzmq                     26.2.0                   pypi_0    pypi
ray                       2.37.0                   pypi_0    pypi
readline                  8.2                  h5eee18b_0  
referencing               0.35.1                   pypi_0    pypi
regex                     2024.9.11                pypi_0    pypi
requests                  2.32.3                   pypi_0    pypi
rfc3339-validator         0.1.4                    pypi_0    pypi
rfc3986-validator         0.1.1                    pypi_0    pypi
rpds-py                   0.20.0                   pypi_0    pypi
safetensors               0.4.5                    pypi_0    pypi
send2trash                1.8.3                    pypi_0    pypi
sentencepiece             0.2.0                    pypi_0    pypi
setuptools                75.1.0          py310h06a4308_0  
six                       1.16.0                   pypi_0    pypi
sniffio                   1.3.1                    pypi_0    pypi
soupsieve                 2.6                      pypi_0    pypi
sqlite                    3.45.3               h5eee18b_0  
stack-data                0.6.3                    pypi_0    pypi
stanza                    1.9.2                    pypi_0    pypi
starlette                 0.38.6                   pypi_0    pypi
sympy                     1.13.3                   pypi_0    pypi
tenacity                  9.0.0                    pypi_0    pypi
terminado                 0.18.1                   pypi_0    pypi
tiktoken                  0.7.0                    pypi_0    pypi
timm                      1.0.12                   pypi_0    pypi
tinycss2                  1.4.0                    pypi_0    pypi
tk                        8.6.14               h39e8969_0  
tokenizers                0.20.0                   pypi_0    pypi
tomli                     2.2.1                    pypi_0    pypi
torch                     2.4.0                    pypi_0    pypi
torchvision               0.19.0                   pypi_0    pypi
tornado                   6.4.2                    pypi_0    pypi
tqdm                      4.66.5                   pypi_0    pypi
traitlets                 5.14.3                   pypi_0    pypi
transformers              4.45.0                   pypi_0    pypi
triton                    3.0.0                    pypi_0    pypi
types-python-dateutil     2.9.0.20241003           pypi_0    pypi
typing-extensions         4.12.2                   pypi_0    pypi
tzdata                    2024.2                   pypi_0    pypi
uri-template              1.3.0                    pypi_0    pypi
urllib3                   2.2.3                    pypi_0    pypi
uvicorn                   0.30.6                   pypi_0    pypi
uvloop                    0.20.0                   pypi_0    pypi
vllm                      0.6.2                    pypi_0    pypi
watchfiles                0.24.0                   pypi_0    pypi
wcwidth                   0.2.13                   pypi_0    pypi
webcolors                 24.11.1                  pypi_0    pypi
webencodings              0.5.1                    pypi_0    pypi
websocket-client          1.8.0                    pypi_0    pypi
websockets                13.1                     pypi_0    pypi
wheel                     0.44.0          py310h06a4308_0  
widgetsnbextension        4.0.13                   pypi_0    pypi
xformers                  0.0.27.post2             pypi_0    pypi
xxhash                    3.5.0                    pypi_0    pypi
xz                        5.4.6                h5eee18b_1  
yarl                      1.12.1                   pypi_0    pypi
zipp                      3.20.2                   pypi_0    pypi
zlib                      1.2.13               h5eee18b_1  
Package                           Version
--------------------------------- --------------
accelerate                        1.1.1
aiohappyeyeballs                  2.4.0
aiohttp                           3.10.6
aiosignal                         1.3.1
annotated-types                   0.7.0
anthropic                         0.40.0
anyio                             4.6.0
argon2-cffi                       23.1.0
argon2-cffi-bindings              21.2.0
arrow                             1.3.0
asttokens                         3.0.0
async-lru                         2.0.4
async-timeout                     4.0.3
attrs                             24.2.0
babel                             2.16.0
beautifulsoup4                    4.12.3
bleach                            6.2.0
certifi                           2024.8.30
cffi                              1.17.1
charset-normalizer                3.3.2
click                             8.1.7
cloudpickle                       3.0.0
comm                              0.2.2
datasets                          3.0.1
debugpy                           1.8.9
decorator                         5.1.1
defusedxml                        0.7.1
dill                              0.3.8
diskcache                         5.6.3
distro                            1.9.0
einops                            0.8.0
emoji                             2.14.0
exceptiongroup                    1.2.2
executing                         2.1.0
fastapi                           0.115.0
fastjsonschema                    2.21.1
filelock                          3.16.1
fqdn                              1.5.1
frozenlist                        1.4.1
fsspec                            2024.6.1
gguf                              0.10.0
h11                               0.14.0
httpcore                          1.0.5
httptools                         0.6.1
httpx                             0.27.2
huggingface-hub                   0.25.1
idna                              3.10
importlib_metadata                8.5.0
interegular                       0.3.3
ipykernel                         6.29.5
ipython                           8.30.0
ipywidgets                        8.1.5
isoduration                       20.11.0
jedi                              0.19.2
Jinja2                            3.1.4
jiter                             0.5.0
json5                             0.10.0
jsonpointer                       3.0.0
jsonschema                        4.23.0
jsonschema-specifications         2023.12.1
jupyter                           1.1.1
jupyter_client                    8.6.3
jupyter-console                   6.6.3
jupyter_core                      5.7.2
jupyter-events                    0.10.0
jupyter-lsp                       2.2.5
jupyter_server                    2.14.2
jupyter_server_terminals          0.5.3
jupyterlab                        4.3.2
jupyterlab_pygments               0.3.0
jupyterlab_server                 2.27.3
jupyterlab_widgets                3.0.13
lark                              1.2.2
llvmlite                          0.43.0
lm-format-enforcer                0.10.6
MarkupSafe                        2.1.5
matplotlib-inline                 0.1.7
mistral_common                    1.4.3
mistune                           3.0.2
mpmath                            1.3.0
msgpack                           1.1.0
msgspec                           0.18.6
multidict                         6.1.0
multiprocess                      0.70.16
nbclient                          0.10.1
nbconvert                         7.16.4
nbformat                          5.10.4
nest-asyncio                      1.6.0
networkx                          3.3
notebook                          7.3.1
notebook_shim                     0.2.4
numba                             0.60.0
numpy                             1.26.4
nvidia-cublas-cu12                12.1.3.1
nvidia-cuda-cupti-cu12            12.1.105
nvidia-cuda-nvrtc-cu12            12.1.105
nvidia-cuda-runtime-cu12          12.1.105
nvidia-cudnn-cu12                 9.1.0.70
nvidia-cufft-cu12                 11.0.2.54
nvidia-curand-cu12                10.3.2.106
nvidia-cusolver-cu12              11.4.5.107
nvidia-cusparse-cu12              12.1.0.106
nvidia-ml-py                      12.560.30
nvidia-nccl-cu12                  2.20.5
nvidia-nvjitlink-cu12             12.6.68
nvidia-nvtx-cu12                  12.1.105
openai                            1.48.0
outlines                          0.0.46
overrides                         7.7.0
packaging                         24.1
pandas                            2.2.3
pandocfilters                     1.5.1
parso                             0.8.4
partial-json-parser               0.2.1.1.post4
pexpect                           4.9.0
pillow                            10.4.0
pip                               24.2
platformdirs                      4.3.6
plotly                            5.24.1
prometheus_client                 0.21.0
prometheus-fastapi-instrumentator 7.0.0
prompt_toolkit                    3.0.48
protobuf                          5.28.2
psutil                            6.0.0
ptyprocess                        0.7.0
pure_eval                         0.2.3
py-cpuinfo                        9.0.0
pyairports                        2.1.1
pyarrow                           17.0.0
pycountry                         24.6.1
pycparser                         2.22
pydantic                          2.9.2
pydantic_core                     2.23.4
Pygments                          2.18.0
python-dateutil                   2.9.0.post0
python-dotenv                     1.0.1
python-json-logger                2.0.7
pytz                              2024.2
PyYAML                            6.0.2
pyzmq                             26.2.0
ray                               2.37.0
referencing                       0.35.1
regex                             2024.9.11
requests                          2.32.3
rfc3339-validator                 0.1.4
rfc3986-validator                 0.1.1
rpds-py                           0.20.0
safetensors                       0.4.5
Send2Trash                        1.8.3
sentencepiece                     0.2.0
setuptools                        75.1.0
six                               1.16.0
sniffio                           1.3.1
soupsieve                         2.6
stack-data                        0.6.3
stanza                            1.9.2
starlette                         0.38.6
sympy                             1.13.3
tenacity                          9.0.0
terminado                         0.18.1
tiktoken                          0.7.0
timm                              1.0.12
tinycss2                          1.4.0
tokenizers                        0.20.0
tomli                             2.2.1
torch                             2.4.0
torchvision                       0.19.0
tornado                           6.4.2
tqdm                              4.66.5
traitlets                         5.14.3
transformers                      4.45.0
triton                            3.0.0
types-python-dateutil             2.9.0.20241003
typing_extensions                 4.12.2
tzdata                            2024.2
uri-template                      1.3.0
urllib3                           2.2.3
uvicorn                           0.30.6
uvloop                            0.20.0
vllm                              0.6.2
watchfiles                        0.24.0
wcwidth                           0.2.13
webcolors                         24.11.1
webencodings                      0.5.1
websocket-client                  1.8.0
websockets                        13.1
wheel                             0.44.0
widgetsnbextension                4.0.13
xformers                          0.0.27.post2
xxhash                            3.5.0
yarl                              1.12.1
zipp                              3.20.2

Currently Loaded Modules:
  1) eth_proxy      3) gcc/12.2.0      5) r/4.3.2       7) python/3.11.6   9) nccl/2.18.3-1    11) python_cuda/3.11.6
  2) julia/1.10.3   4) stack/2024-06   6) hdf5/1.14.3   8) cuda/12.1.1    10) openblas/0.3.24

 

Testing Slurm Variables...
SLURM_JOB_USER=gcardenal
SLURM_TASKS_PER_NODE=1
SLURM_JOB_UID=608619
SLURM_TASK_PID=4030050
SLURM_JOB_GPUS=4,8
SLURM_LOCALID=0
SLURM_SUBMIT_DIR=/cluster/home/gcardenal/HIV/deploy_medical_LLM_evaluation/deploy_medical_llm_evaluation
SLURMD_NODENAME=eu-a65-05
SLURM_JOB_START_TIME=1736934174
SLURM_CLUSTER_NAME=euler-24-production
SLURM_JOB_END_TIME=1736948574
SLURM_CPUS_ON_NODE=8
SLURM_JOB_CPUS_PER_NODE=8
SLURM_GPUS_ON_NODE=2
SLURM_GTIDS=0
SLURM_JOB_PARTITION=gpupr.4h
SLURM_TRES_PER_TASK=cpu=8
SLURM_JOB_NUM_NODES=1
SLURM_JOBID=20835073
SLURM_GPUS=nvidia_a100_80gb_pcie:2
SLURM_JOB_QOS=es_ilic/gpupr/4
SLURM_PROCID=0
SLURM_CPUS_PER_TASK=8
SLURM_NTASKS=1
SLURM_TOPOLOGY_ADDR=.euler_a100_80_lca_ib.eu-a65-05
SLURM_TOPOLOGY_ADDR_PATTERN=switch.switch.node
SLURM_MEM_PER_CPU=10240
SLURM_SCRIPT_CONTEXT=prolog_task
SLURM_NODELIST=eu-a65-05
SLURM_JOB_ACCOUNT=gpupr/es_ilic
SLURM_PRIO_PROCESS=0
SLURM_NPROCS=1
SLURM_NNODES=1
SLURM_SUBMIT_HOST=eu-g9-021-4
SLURM_JOB_ID=20835073
SLURM_NODEID=0
SLURM_CONF=/cluster/slurm/adm/etc/slurm.conf
SLURM_JOB_NAME=llama_no_api
SLURM_JOB_GID=492010
SLURM_JOB_NODELIST=eu-a65-05
Wed Jan 15 10:43:07 2025       
+-----------------------------------------------------------------------------------------+
| NVIDIA-SMI 550.127.05             Driver Version: 550.127.05     CUDA Version: 12.4     |
|-----------------------------------------+------------------------+----------------------+
| GPU  Name                 Persistence-M | Bus-Id          Disp.A | Volatile Uncorr. ECC |
| Fan  Temp   Perf          Pwr:Usage/Cap |           Memory-Usage | GPU-Util  Compute M. |
|                                         |                        |               MIG M. |
|=========================================+========================+======================|
|   0  NVIDIA A100 80GB PCIe          On  |   00000000:4C:00.0 Off |                    0 |
| N/A   32C    P0             43W /  300W |       1MiB /  81920MiB |      0%      Default |
|                                         |                        |             Disabled |
+-----------------------------------------+------------------------+----------------------+
|   1  NVIDIA A100 80GB PCIe          On  |   00000000:CC:00.0 Off |                    0 |
| N/A   33C    P0             43W /  300W |       1MiB /  81920MiB |      0%      Default |
|                                         |                        |             Disabled |
+-----------------------------------------+------------------------+----------------------+
                                                                                         
+-----------------------------------------------------------------------------------------+
| Processes:                                                                              |
|  GPU   GI   CI        PID   Type   Process name                              GPU Memory |
|        ID   ID                                                               Usage      |
|=========================================================================================|
|  No running processes found                                                             |
+-----------------------------------------------------------------------------------------+
Node IP: 10.205.9.14
JobId=20835073 JobName=llama_no_api
   UserId=gcardenal(608619) GroupId=gcardenal-group(492010) MCS_label=N/A
   Priority=5810 Nice=0 Account=gpupr/es_ilic QOS=es_ilic/gpupr/4
   JobState=RUNNING Reason=None Dependency=(null)
   Requeue=0 Restarts=0 BatchFlag=1 Reboot=0 ExitCode=0:0
   RunTime=00:00:14 TimeLimit=04:00:00 TimeMin=N/A
   SubmitTime=2025-01-15T10:42:50 EligibleTime=2025-01-15T10:42:50
   AccrueTime=2025-01-15T10:42:50
   StartTime=2025-01-15T10:42:54 EndTime=2025-01-15T14:42:54 Deadline=N/A
   SuspendTime=None SecsPreSuspend=0 LastSchedEval=2025-01-15T10:42:54 Scheduler=Backfill
   Partition=gpupr.4h AllocNode:Sid=eu-g9-021-4:1343445
   ReqNodeList=(null) ExcNodeList=(null)
   NodeList=eu-a65-05
   BatchHost=eu-a65-05
   NumNodes=1 NumCPUs=8 NumTasks=1 CPUs/Task=8 ReqB:S:C:T=0:0:*:*
   ReqTRES=cpu=8,mem=80G,node=1,billing=347340,gres/gpu=2,gres/gpu:nvidia_a100_80gb_pcie=2,gres/gpumem=85899345920
   AllocTRES=cpu=8,mem=80G,node=1,billing=347340,gres/gpu=2,gres/gpu:nvidia_a100_80gb_pcie=2,gres/gpumem=0
   Socks/Node=* NtasksPerN:B:S:C=0:0:*:1 CoreSpec=*
   MinCPUsNode=8 MinMemoryCPU=10G MinTmpDiskNode=0
   Features=(null) DelayBoot=00:00:00
   OverSubscribe=OK Contiguous=0 Licenses=(null) Network=(null)
   Command=/cluster/home/gcardenal/HIV/deploy_medical_LLM_evaluation/deploy_medical_llm_evaluation/generate_answers.sh
   WorkDir=/cluster/home/gcardenal/HIV/deploy_medical_LLM_evaluation/deploy_medical_llm_evaluation
   StdErr=/cluster/home/gcardenal/HIV/deploy_medical_LLM_evaluation/deploy_medical_llm_evaluation/llama_no_api20835073.out
   StdIn=/dev/null
   StdOut=/cluster/home/gcardenal/HIV/deploy_medical_LLM_evaluation/deploy_medical_llm_evaluation/llama_no_api20835073.out
   TresPerJob=gres/gpu:nvidia_a100_80gb_pcie:2
   TresPerNode=gres/gpumem:80G
   TresPerTask=cpu=8
   

Running in standalone mode...
I0115 10:43:10.391000 23290779203392 torch/distributed/run.py:859] 
I0115 10:43:10.391000 23290779203392 torch/distributed/run.py:859] **************************************
I0115 10:43:10.391000 23290779203392 torch/distributed/run.py:859] Rendezvous info:
I0115 10:43:10.391000 23290779203392 torch/distributed/run.py:859] --rdzv-backend=c10d --rdzv-endpoint=localhost:0 --rdzv-id=41b3900c-0b2f-4a7f-b3ee-8e6766eecbff
I0115 10:43:10.391000 23290779203392 torch/distributed/run.py:859] **************************************
I0115 10:43:10.391000 23290779203392 torch/distributed/run.py:859] 
I0115 10:43:10.392000 23290779203392 torch/distributed/launcher/api.py:188] Starting elastic_operator with launch configs:
I0115 10:43:10.392000 23290779203392 torch/distributed/launcher/api.py:188]   entrypoint       : get_model_answers_and_prompt_generation.py
I0115 10:43:10.392000 23290779203392 torch/distributed/launcher/api.py:188]   min_nodes        : 1
I0115 10:43:10.392000 23290779203392 torch/distributed/launcher/api.py:188]   max_nodes        : 1
I0115 10:43:10.392000 23290779203392 torch/distributed/launcher/api.py:188]   nproc_per_node   : 1
I0115 10:43:10.392000 23290779203392 torch/distributed/launcher/api.py:188]   run_id           : 41b3900c-0b2f-4a7f-b3ee-8e6766eecbff
I0115 10:43:10.392000 23290779203392 torch/distributed/launcher/api.py:188]   rdzv_backend     : c10d
I0115 10:43:10.392000 23290779203392 torch/distributed/launcher/api.py:188]   rdzv_endpoint    : localhost:0
I0115 10:43:10.392000 23290779203392 torch/distributed/launcher/api.py:188]   rdzv_configs     : {'timeout': 900}
I0115 10:43:10.392000 23290779203392 torch/distributed/launcher/api.py:188]   max_restarts     : 0
I0115 10:43:10.392000 23290779203392 torch/distributed/launcher/api.py:188]   monitor_interval : 5
I0115 10:43:10.392000 23290779203392 torch/distributed/launcher/api.py:188]   log_dir          : /scratch/tmp.20835073.gcardenal/torchelastic_wglnin5n
I0115 10:43:10.392000 23290779203392 torch/distributed/launcher/api.py:188]   metrics_cfg      : {}
I0115 10:43:10.392000 23290779203392 torch/distributed/launcher/api.py:188] 
I0115 10:43:10.401000 23290779203392 torch/distributed/elastic/agent/server/api.py:866] [default] starting workers for entrypoint: python3
I0115 10:43:10.401000 23290779203392 torch/distributed/elastic/agent/server/api.py:699] [default] Rendezvous'ing worker group
I0115 10:43:10.662000 23290779203392 torch/distributed/elastic/agent/server/api.py:568] [default] Rendezvous complete for workers. Result:
I0115 10:43:10.662000 23290779203392 torch/distributed/elastic/agent/server/api.py:568]   restart_count=0
I0115 10:43:10.662000 23290779203392 torch/distributed/elastic/agent/server/api.py:568]   master_addr=eu-a65-05.euler.ethz.ch
I0115 10:43:10.662000 23290779203392 torch/distributed/elastic/agent/server/api.py:568]   master_port=45245
I0115 10:43:10.662000 23290779203392 torch/distributed/elastic/agent/server/api.py:568]   group_rank=0
I0115 10:43:10.662000 23290779203392 torch/distributed/elastic/agent/server/api.py:568]   group_world_size=1
I0115 10:43:10.662000 23290779203392 torch/distributed/elastic/agent/server/api.py:568]   local_ranks=[0]
I0115 10:43:10.662000 23290779203392 torch/distributed/elastic/agent/server/api.py:568]   role_ranks=[0]
I0115 10:43:10.662000 23290779203392 torch/distributed/elastic/agent/server/api.py:568]   global_ranks=[0]
I0115 10:43:10.662000 23290779203392 torch/distributed/elastic/agent/server/api.py:568]   role_world_sizes=[1]
I0115 10:43:10.662000 23290779203392 torch/distributed/elastic/agent/server/api.py:568]   global_world_sizes=[1]
I0115 10:43:10.662000 23290779203392 torch/distributed/elastic/agent/server/api.py:568] 
I0115 10:43:10.662000 23290779203392 torch/distributed/elastic/agent/server/api.py:707] [default] Starting worker group
I0115 10:43:10.663000 23290779203392 torch/distributed/elastic/agent/server/local_elastic_agent.py:168] Environment variable 'TORCHELASTIC_ENABLE_FILE_TIMER' not found. Do not start FileTimerServer.
I0115 10:43:10.663000 23290779203392 torch/distributed/elastic/multiprocessing/api.py:263] log directory set to: /scratch/tmp.20835073.gcardenal/torchelastic_wglnin5n/41b3900c-0b2f-4a7f-b3ee-8e6766eecbff_pjbr10ms
I0115 10:43:10.664000 23290779203392 torch/distributed/elastic/multiprocessing/api.py:358] Setting worker0 reply file to: /scratch/tmp.20835073.gcardenal/torchelastic_wglnin5n/41b3900c-0b2f-4a7f-b3ee-8e6766eecbff_pjbr10ms/attempt_0/0/error.json
2025-01-15 10:43:16.552288: E external/local_xla/xla/stream_executor/cuda/cuda_dnn.cc:9261] Unable to register cuDNN factory: Attempting to register factory for plugin cuDNN when one has already been registered
2025-01-15 10:43:16.552344: E external/local_xla/xla/stream_executor/cuda/cuda_fft.cc:607] Unable to register cuFFT factory: Attempting to register factory for plugin cuFFT when one has already been registered
2025-01-15 10:43:16.554034: E external/local_xla/xla/stream_executor/cuda/cuda_blas.cc:1515] Unable to register cuBLAS factory: Attempting to register factory for plugin cuBLAS when one has already been registered
2025-01-15 10:43:16.560549: I tensorflow/core/platform/cpu_feature_guard.cc:182] This TensorFlow binary is optimized to use available CPU instructions in performance-critical operations.
To enable the following instructions: AVX2 FMA, in other operations, rebuild TensorFlow with the appropriate compiler flags.
2025-01-15 10:43:18.111027: W tensorflow/compiler/tf2tensorrt/utils/py_utils.cc:38] TF-TRT Warning: Could not find TensorRT
API call for Llama failed with error: Connection error.
Falling back to local Llama inference - Loading model...
Loading checkpoint shards:   0%|                                                                                                       | 0/30 [00:00<?, ?it/s]Loading checkpoint shards:   3%|███▏                                                                                           | 1/30 [00:13<06:39, 13.76s/it]Loading checkpoint shards:   7%|██████▎                                                                                        | 2/30 [00:24<05:38, 12.10s/it]Loading checkpoint shards:  10%|█████████▌                                                                                     | 3/30 [00:35<05:14, 11.63s/it]Loading checkpoint shards:  13%|████████████▋                                                                                  | 4/30 [00:43<04:17,  9.90s/it]Loading checkpoint shards:  17%|███████████████▊                                                                               | 5/30 [00:54<04:22, 10.50s/it]Loading checkpoint shards:  20%|███████████████████                                                                            | 6/30 [01:26<07:04, 17.70s/it]Loading checkpoint shards:  23%|██████████████████████▏                                                                        | 7/30 [01:33<05:27, 14.22s/it]Loading checkpoint shards:  27%|█████████████████████████▎                                                                     | 8/30 [01:39<04:15, 11.61s/it]Loading checkpoint shards:  30%|████████████████████████████▌                                                                  | 9/30 [01:46<03:34, 10.22s/it]Loading checkpoint shards:  33%|███████████████████████████████▎                                                              | 10/30 [01:52<02:58,  8.91s/it]Loading checkpoint shards:  37%|██████████████████████████████████▍                                                           | 11/30 [02:01<02:47,  8.81s/it]Loading checkpoint shards:  40%|█████████████████████████████████████▌                                                        | 12/30 [02:07<02:26,  8.12s/it]Loading checkpoint shards:  43%|████████████████████████████████████████▋                                                     | 13/30 [02:21<02:49,  9.98s/it]Loading checkpoint shards:  47%|███████████████████████████████████████████▊                                                  | 14/30 [02:32<02:41, 10.08s/it]Loading checkpoint shards:  50%|███████████████████████████████████████████████                                               | 15/30 [02:40<02:21,  9.42s/it]Loading checkpoint shards:  53%|██████████████████████████████████████████████████▏                                           | 16/30 [02:46<01:57,  8.40s/it]Loading checkpoint shards:  57%|█████████████████████████████████████████████████████▎                                        | 17/30 [02:52<01:42,  7.87s/it]Loading checkpoint shards:  60%|████████████████████████████████████████████████████████▍                                     | 18/30 [03:14<02:23, 11.92s/it]Loading checkpoint shards:  63%|███████████████████████████████████████████████████████████▌                                  | 19/30 [03:55<03:49, 20.86s/it]Loading checkpoint shards:  67%|██████████████████████████████████████████████████████████████▋                               | 20/30 [04:02<02:45, 16.56s/it]Loading checkpoint shards:  70%|█████████████████████████████████████████████████████████████████▊                            | 21/30 [04:10<02:07, 14.12s/it]Loading checkpoint shards:  73%|████████████████████████████████████████████████████████████████████▉                         | 22/30 [04:17<01:35, 11.89s/it]Loading checkpoint shards:  77%|████████████████████████████████████████████████████████████████████████                      | 23/30 [04:29<01:24, 12.04s/it]Loading checkpoint shards:  80%|███████████████████████████████████████████████████████████████████████████▏                  | 24/30 [04:37<01:04, 10.70s/it]Loading checkpoint shards:  83%|██████████████████████████████████████████████████████████████████████████████▎               | 25/30 [04:49<00:55, 11.09s/it]Loading checkpoint shards:  87%|█████████████████████████████████████████████████████████████████████████████████▍            | 26/30 [04:58<00:41, 10.42s/it]Loading checkpoint shards:  90%|████████████████████████████████████████████████████████████████████████████████████▌         | 27/30 [05:04<00:27,  9.24s/it]Loading checkpoint shards:  93%|███████████████████████████████████████████████████████████████████████████████████████▋      | 28/30 [05:11<00:17,  8.61s/it]Loading checkpoint shards:  97%|██████████████████████████████████████████████████████████████████████████████████████████▊   | 29/30 [05:25<00:10, 10.26s/it]Loading checkpoint shards: 100%|██████████████████████████████████████████████████████████████████████████████████████████████| 30/30 [05:29<00:00,  8.14s/it]Loading checkpoint shards: 100%|██████████████████████████████████████████████████████████████████████████████████████████████| 30/30 [05:29<00:00, 10.97s/it]
Starting inference for question locally (Llama): How is HIV diagnosed?
{'role': 'assistant', 'content': 'HIV (Human Immunodeficiency Virus) diagnosis typically involves a combination of medical history, physical examination, and laboratory tests. Here\'s an overview of the diagnostic process:\n\n1. **Medical History and Risk Assessment**: A healthcare provider will ask questions about your medical history, including any symptoms, sexual history, and potential exposure to HIV.\n2. **Physical Examination**: A physical examination may be performed to look for signs of HIV infection, such as swollen lymph nodes, skin rashes, or oral thrush.\n3. **Laboratory Tests**: The following laboratory tests are used to diagnose HIV:\n\t* **Rapid Tests**: These are quick tests that can provide results in 20-30 minutes. They detect the presence of HIV antibodies in blood, saliva, or urine.\n\t* **Enzyme-Linked Immunosorbent Assay (ELISA)**: This test detects HIV antibodies in blood and is often used as a follow-up to a rapid test.\n\t* **Western Blot**: This test is used to confirm the diagnosis of HIV infection. It detects the presence of HIV antibodies and can identify the specific type of HIV (HIV-1 or HIV-2).\n\t* **Nucleic Acid Tests (NAT)**: These tests detect the genetic material of the virus (RNA or DNA) in blood. NAT is often used to diagnose HIV in infants born to HIV-positive mothers or to detect early infection.\n\t* **CD4 Cell Count**: This test measures the number of CD4 cells (a type of immune cell) in the blood. A low CD4 count can indicate HIV infection.\n4. **Window Period**: It\'s essential to note that there is a "window period" between HIV infection and the development of detectable antibodies. During this time, a person may not test positive for HIV, even if they are infected. The window period can vary from 2-12 weeks, depending on the test used.\n5. **Confirmatory Testing**: If an initial test is positive, a confirmatory test is usually performed to rule out false positives.\n6. **Staging and Monitoring**: Once diagnosed, HIV infection is staged using the CDC\'s classification system, which takes into account the CD4 cell count and the presence of symptoms. Regular monitoring of viral load, CD4 count, and other health indicators is essential to manage the infection and prevent complications.\n\nIt\'s crucial to get tested if you:\n\n* Have had unprotected sex with someone who is HIV-positive or whose HIV status is unknown\n* Have shared needles or syringes\n* Have received a blood transfusion or organ transplant before 1985\n* Have been diagnosed with another sexually transmitted infection (STI)\n* Are pregnant or planning to become pregnant\n\nRemember, early diagnosis and treatment can significantly improve the quality of life and life expectancy for people living with HIV.'}
HIV (Human Immunodeficiency Virus) diagnosis typically involves a combination of medical history, physical examination, and laboratory tests. Here's an overview of the diagnostic process:

1. **Medical History and Risk Assessment**: A healthcare provider will ask questions about your medical history, including any symptoms, sexual history, and potential exposure to HIV.
2. **Physical Examination**: A physical examination may be performed to look for signs of HIV infection, such as swollen lymph nodes, skin rashes, or oral thrush.
3. **Laboratory Tests**: The following laboratory tests are used to diagnose HIV:
	* **Rapid Tests**: These are quick tests that can provide results in 20-30 minutes. They detect the presence of HIV antibodies in blood, saliva, or urine.
	* **Enzyme-Linked Immunosorbent Assay (ELISA)**: This test detects HIV antibodies in blood and is often used as a follow-up to a rapid test.
	* **Western Blot**: This test is used to confirm the diagnosis of HIV infection. It detects the presence of HIV antibodies and can identify the specific type of HIV (HIV-1 or HIV-2).
	* **Nucleic Acid Tests (NAT)**: These tests detect the genetic material of the virus (RNA or DNA) in blood. NAT is often used to diagnose HIV in infants born to HIV-positive mothers or to detect early infection.
	* **CD4 Cell Count**: This test measures the number of CD4 cells (a type of immune cell) in the blood. A low CD4 count can indicate HIV infection.
4. **Window Period**: It's essential to note that there is a "window period" between HIV infection and the development of detectable antibodies. During this time, a person may not test positive for HIV, even if they are infected. The window period can vary from 2-12 weeks, depending on the test used.
5. **Confirmatory Testing**: If an initial test is positive, a confirmatory test is usually performed to rule out false positives.
6. **Staging and Monitoring**: Once diagnosed, HIV infection is staged using the CDC's classification system, which takes into account the CD4 cell count and the presence of symptoms. Regular monitoring of viral load, CD4 count, and other health indicators is essential to manage the infection and prevent complications.

It's crucial to get tested if you:

* Have had unprotected sex with someone who is HIV-positive or whose HIV status is unknown
* Have shared needles or syringes
* Have received a blood transfusion or organ transplant before 1985
* Have been diagnosed with another sexually transmitted infection (STI)
* Are pregnant or planning to become pregnant

Remember, early diagnosis and treatment can significantly improve the quality of life and life expectancy for people living with HIV.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): What are the different stages of HIV?
{'role': 'assistant', 'content': "HIV (Human Immunodeficiency Virus) infection progresses through several stages, which can vary in duration and severity from person to person. The stages of HIV infection are:\n\n**Stage 1: Acute HIV Infection (0-6 weeks)**\n\n* This is the initial stage of HIV infection, which occurs when the virus first enters the body.\n* During this stage, the virus replicates rapidly, and the person may experience flu-like symptoms, such as fever, headache, and fatigue.\n* The viral load is high, and the person is highly infectious.\n\n**Stage 2: Clinical Latency (6 weeks to 10 years or more)**\n\n* After the acute stage, the virus enters a latent phase, during which the person may not exhibit any symptoms.\n* The viral load decreases, and the immune system tries to fight the infection.\n* The person can still transmit the virus to others, even if they don't show any symptoms.\n\n**Stage 3: Symptomatic HIV Infection (10 years or more)**\n\n* As the virus continues to replicate, the person may start to experience symptoms, such as:\n\t+ Weight loss\n\t+ Diarrhea\n\t+ Fever\n\t+ Night sweats\n\t+ Swollen lymph nodes\n\t+ Skin rashes\n* The immune system is weakened, making the person more susceptible to opportunistic infections (OIs).\n\n**Stage 4: AIDS (Acquired Immunodeficiency Syndrome)**\n\n* AIDS is the most advanced stage of HIV infection, which occurs when the immune system is severely damaged.\n* The person's CD4 cell count (a type of immune cell) falls below 200 cells per cubic millimeter of blood.\n* The person is highly susceptible to OIs, such as:\n\t+ Pneumocystis pneumonia (PCP)\n\t+ Toxoplasmosis\n\t+ Kaposi's sarcoma\n\t+ Lymphoma\n* Without treatment, AIDS can lead to death.\n\n**Undetectable Viral Load**\n\n* With effective antiretroviral therapy (ART), the viral load can be suppressed to undetectable levels.\n* This means that the virus is still present, but it is not detectable in the blood.\n* People with an undetectable viral load can still transmit the virus, but the risk is significantly reduced.\n\nIt's essential to note that with proper treatment and care, people living with HIV can manage the disease and prevent progression to AIDS. Early diagnosis, treatment, and adherence to medication can significantly improve the quality of life and life expectancy for individuals with HIV."}
HIV (Human Immunodeficiency Virus) infection progresses through several stages, which can vary in duration and severity from person to person. The stages of HIV infection are:

**Stage 1: Acute HIV Infection (0-6 weeks)**

* This is the initial stage of HIV infection, which occurs when the virus first enters the body.
* During this stage, the virus replicates rapidly, and the person may experience flu-like symptoms, such as fever, headache, and fatigue.
* The viral load is high, and the person is highly infectious.

**Stage 2: Clinical Latency (6 weeks to 10 years or more)**

* After the acute stage, the virus enters a latent phase, during which the person may not exhibit any symptoms.
* The viral load decreases, and the immune system tries to fight the infection.
* The person can still transmit the virus to others, even if they don't show any symptoms.

**Stage 3: Symptomatic HIV Infection (10 years or more)**

* As the virus continues to replicate, the person may start to experience symptoms, such as:
	+ Weight loss
	+ Diarrhea
	+ Fever
	+ Night sweats
	+ Swollen lymph nodes
	+ Skin rashes
* The immune system is weakened, making the person more susceptible to opportunistic infections (OIs).

**Stage 4: AIDS (Acquired Immunodeficiency Syndrome)**

* AIDS is the most advanced stage of HIV infection, which occurs when the immune system is severely damaged.
* The person's CD4 cell count (a type of immune cell) falls below 200 cells per cubic millimeter of blood.
* The person is highly susceptible to OIs, such as:
	+ Pneumocystis pneumonia (PCP)
	+ Toxoplasmosis
	+ Kaposi's sarcoma
	+ Lymphoma
* Without treatment, AIDS can lead to death.

**Undetectable Viral Load**

* With effective antiretroviral therapy (ART), the viral load can be suppressed to undetectable levels.
* This means that the virus is still present, but it is not detectable in the blood.
* People with an undetectable viral load can still transmit the virus, but the risk is significantly reduced.

It's essential to note that with proper treatment and care, people living with HIV can manage the disease and prevent progression to AIDS. Early diagnosis, treatment, and adherence to medication can significantly improve the quality of life and life expectancy for individuals with HIV.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): How is HIV transmitted?
{'role': 'assistant', 'content': "HIV (Human Immunodeficiency Virus) is transmitted through certain bodily fluids from a person who has a detectable viral load and is not taking antiretroviral therapy (ART) or is not virally suppressed. The main ways HIV is transmitted are:\n\n1. **Sexual contact**: HIV can be transmitted through vaginal, anal, or oral sex with an infected person. The risk of transmission is higher for anal sex and lower for oral sex.\n2. **Blood-to-blood contact**: HIV can be transmitted through:\n\t* Sharing needles or syringes with an infected person.\n\t* Blood transfusions from an infected donor (although this is rare in countries with strict blood screening protocols).\n\t* Organ transplants from an infected donor.\n3. **Mother-to-child transmission**: HIV can be transmitted from an infected mother to her child during:\n\t* Pregnancy (in utero).\n\t* Childbirth (during labor and delivery).\n\t* Breastfeeding.\n4. **Occupational exposure**: Healthcare workers can be at risk of HIV transmission through:\n\t* Needlestick injuries.\n\t* Exposure to infected blood or bodily fluids through cuts or abrasions.\n\nIt's essential to note that HIV is not transmitted through:\n\n* Casual contact, such as hugging, shaking hands, or sharing food and drinks.\n* Air or water.\n* Insect bites.\n* Saliva, sweat, or tears, unless they are mixed with blood.\n\nTo reduce the risk of HIV transmission, it's crucial to:\n\n* Practice safe sex, such as using condoms consistently and correctly.\n* Use sterile needles and syringes for injecting drugs.\n* Get tested for HIV regularly, especially if you're at high risk.\n* Take antiretroviral therapy (ART) if you're living with HIV to suppress the virus and prevent transmission.\n* Follow proper infection control protocols in healthcare settings.\n\nRemember, HIV is a manageable condition with proper treatment and care. If you have any concerns or questions, consult a healthcare professional or a trusted resource."}
HIV (Human Immunodeficiency Virus) is transmitted through certain bodily fluids from a person who has a detectable viral load and is not taking antiretroviral therapy (ART) or is not virally suppressed. The main ways HIV is transmitted are:

1. **Sexual contact**: HIV can be transmitted through vaginal, anal, or oral sex with an infected person. The risk of transmission is higher for anal sex and lower for oral sex.
2. **Blood-to-blood contact**: HIV can be transmitted through:
	* Sharing needles or syringes with an infected person.
	* Blood transfusions from an infected donor (although this is rare in countries with strict blood screening protocols).
	* Organ transplants from an infected donor.
3. **Mother-to-child transmission**: HIV can be transmitted from an infected mother to her child during:
	* Pregnancy (in utero).
	* Childbirth (during labor and delivery).
	* Breastfeeding.
4. **Occupational exposure**: Healthcare workers can be at risk of HIV transmission through:
	* Needlestick injuries.
	* Exposure to infected blood or bodily fluids through cuts or abrasions.

It's essential to note that HIV is not transmitted through:

* Casual contact, such as hugging, shaking hands, or sharing food and drinks.
* Air or water.
* Insect bites.
* Saliva, sweat, or tears, unless they are mixed with blood.

To reduce the risk of HIV transmission, it's crucial to:

* Practice safe sex, such as using condoms consistently and correctly.
* Use sterile needles and syringes for injecting drugs.
* Get tested for HIV regularly, especially if you're at high risk.
* Take antiretroviral therapy (ART) if you're living with HIV to suppress the virus and prevent transmission.
* Follow proper infection control protocols in healthcare settings.

Remember, HIV is a manageable condition with proper treatment and care. If you have any concerns or questions, consult a healthcare professional or a trusted resource.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): What comorbidities are common among people living 
{'role': 'assistant', 'content': "People living with HIV (PLWH) are at increased risk for various comorbidities, which are health conditions that occur simultaneously with HIV infection. Some common comorbidities among PLWH include:\n\n1. **Mental health disorders**: Depression, anxiety, post-traumatic stress disorder (PTSD), and substance use disorders are common among PLWH.\n2. **Cardiovascular disease**: PLWH are at higher risk for cardiovascular disease, including heart attacks, strokes, and peripheral artery disease, due to inflammation, antiretroviral therapy (ART) side effects, and traditional risk factors like smoking and hypertension.\n3. **Chronic kidney disease**: HIV infection can damage the kidneys, and PLWH are at higher risk for chronic kidney disease, particularly if they have a history of diabetes, hypertension, or other kidney problems.\n4. **Liver disease**: Co-infection with hepatitis B or C viruses, as well as ART side effects, can increase the risk of liver disease, including cirrhosis and liver cancer.\n5. **Cancer**: PLWH are at higher risk for certain types of cancer, including:\n\t* Kaposi's sarcoma\n\t* Non-Hodgkin lymphoma\n\t* Cervical cancer\n\t* Anal cancer\n\t* Lung cancer\n\t* Liver cancer\n6. **Osteoporosis**: PLWH are at higher risk for osteoporosis, particularly if they have a history of smoking, low body mass index (BMI), or certain ART regimens.\n7. **Diabetes**: PLWH are at higher risk for developing type 2 diabetes, particularly if they have a family history of diabetes, are overweight or obese, or have certain ART regimens.\n8. **Hypertension**: PLWH are at higher risk for developing hypertension, particularly if they have a family history of hypertension, are overweight or obese, or have certain ART regimens.\n9. **Gastrointestinal disorders**: PLWH are at higher risk for gastrointestinal disorders, including:\n\t* Gastroesophageal reflux disease (GERD)\n\t* Irritable bowel syndrome (IBS)\n\t* Inflammatory bowel disease (IBD)\n10. **Neurological disorders**: PLWH are at higher risk for neurological disorders, including:\n\t* HIV-associated neurocognitive disorder (HAND)\n\t* Peripheral neuropathy\n\t* Seizure disorders\n\t* Stroke\n11. **Sleep disorders**: PLWH are at higher risk for sleep disorders, including insomnia, sleep apnea, and restless leg syndrome.\n12. **Malnutrition and wasting**: PLWH, particularly those with advanced disease or those not on effective ART, are at risk for malnutrition and wasting.\n13. **Dental problems**: PLWH are at higher risk for dental problems, including periodontal disease, tooth loss, and oral candidiasis.\n14. **Sexually transmitted infections (STIs)**: PLWH are at higher risk for STIs, including gonorrhea, chlamydia, and syphilis.\n\nIt's essential for PLWH to work closely with their healthcare providers to manage these comorbidities and prevent complications. Regular health check-ups, screenings, and preventive measures can help mitigate the risks associated with these comorbidities."}
People living with HIV (PLWH) are at increased risk for various comorbidities, which are health conditions that occur simultaneously with HIV infection. Some common comorbidities among PLWH include:

1. **Mental health disorders**: Depression, anxiety, post-traumatic stress disorder (PTSD), and substance use disorders are common among PLWH.
2. **Cardiovascular disease**: PLWH are at higher risk for cardiovascular disease, including heart attacks, strokes, and peripheral artery disease, due to inflammation, antiretroviral therapy (ART) side effects, and traditional risk factors like smoking and hypertension.
3. **Chronic kidney disease**: HIV infection can damage the kidneys, and PLWH are at higher risk for chronic kidney disease, particularly if they have a history of diabetes, hypertension, or other kidney problems.
4. **Liver disease**: Co-infection with hepatitis B or C viruses, as well as ART side effects, can increase the risk of liver disease, including cirrhosis and liver cancer.
5. **Cancer**: PLWH are at higher risk for certain types of cancer, including:
	* Kaposi's sarcoma
	* Non-Hodgkin lymphoma
	* Cervical cancer
	* Anal cancer
	* Lung cancer
	* Liver cancer
6. **Osteoporosis**: PLWH are at higher risk for osteoporosis, particularly if they have a history of smoking, low body mass index (BMI), or certain ART regimens.
7. **Diabetes**: PLWH are at higher risk for developing type 2 diabetes, particularly if they have a family history of diabetes, are overweight or obese, or have certain ART regimens.
8. **Hypertension**: PLWH are at higher risk for developing hypertension, particularly if they have a family history of hypertension, are overweight or obese, or have certain ART regimens.
9. **Gastrointestinal disorders**: PLWH are at higher risk for gastrointestinal disorders, including:
	* Gastroesophageal reflux disease (GERD)
	* Irritable bowel syndrome (IBS)
	* Inflammatory bowel disease (IBD)
10. **Neurological disorders**: PLWH are at higher risk for neurological disorders, including:
	* HIV-associated neurocognitive disorder (HAND)
	* Peripheral neuropathy
	* Seizure disorders
	* Stroke
11. **Sleep disorders**: PLWH are at higher risk for sleep disorders, including insomnia, sleep apnea, and restless leg syndrome.
12. **Malnutrition and wasting**: PLWH, particularly those with advanced disease or those not on effective ART, are at risk for malnutrition and wasting.
13. **Dental problems**: PLWH are at higher risk for dental problems, including periodontal disease, tooth loss, and oral candidiasis.
14. **Sexually transmitted infections (STIs)**: PLWH are at higher risk for STIs, including gonorrhea, chlamydia, and syphilis.

It's essential for PLWH to work closely with their healthcare providers to manage these comorbidities and prevent complications. Regular health check-ups, screenings, and preventive measures can help mitigate the risks associated with these comorbidities.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): How can HIV be prevented?
{'role': 'assistant', 'content': 'HIV (Human Immunodeficiency Virus) can be prevented through a combination of strategies that reduce the risk of transmission. Here are some effective ways to prevent HIV:\n\n1. **Use condoms**: Consistent and correct use of condoms during vaginal, anal, and oral sex can significantly reduce the risk of HIV transmission.\n2. **Practice safe sex**: Avoid having multiple sex partners, and get tested for HIV and other STIs regularly.\n3. **Get tested and treated for STIs**: Many STIs, such as gonorrhea and chlamydia, can increase the risk of HIV transmission. Getting tested and treated for STIs can help prevent HIV.\n4. **Use pre-exposure prophylaxis (PrEP)**: PrEP is a daily medication that can help prevent HIV infection in people who are at high risk of exposure.\n5. **Use post-exposure prophylaxis (PEP)**: PEP is an emergency medication that can help prevent HIV infection if taken within 72 hours of exposure.\n6. **Avoid sharing needles**: Sharing needles or syringes can spread HIV and other bloodborne pathogens. Use sterile needles and syringes, and avoid sharing equipment.\n7. **Get vaccinated against hepatitis B**: Hepatitis B and HIV can be transmitted through similar routes, and getting vaccinated against hepatitis B can help reduce the risk of HIV transmission.\n8. **Use harm reduction services**: Harm reduction services, such as needle exchange programs and safe injection sites, can help reduce the risk of HIV transmission among people who inject drugs.\n9. **Choose a mutually monogamous relationship**: Being in a mutually monogamous relationship with someone who is HIV-negative can reduce the risk of HIV transmission.\n10. **Get tested for HIV**: Knowing your HIV status can help you take steps to prevent transmission and get treatment if you are infected.\n11. **Use dental dams**: Dental dams can help prevent HIV transmission during oral sex.\n12. **Avoid douching**: Douching can increase the risk of HIV transmission by disrupting the natural balance of bacteria in the vagina.\n13. **Use lubricants**: Using lubricants can help reduce the risk of condom breakage and HIV transmission.\n14. **Get educated**: Learn about HIV transmission, prevention, and treatment to make informed decisions about your health.\n15. **Support HIV prevention programs**: Support programs that provide HIV prevention services, such as testing, counseling, and education, to help reduce the spread of HIV.\n\nRemember, HIV prevention is a shared responsibility, and everyone can play a role in reducing the spread of the virus. By taking these steps, you can help protect yourself and others from HIV infection.'}
HIV (Human Immunodeficiency Virus) can be prevented through a combination of strategies that reduce the risk of transmission. Here are some effective ways to prevent HIV:

1. **Use condoms**: Consistent and correct use of condoms during vaginal, anal, and oral sex can significantly reduce the risk of HIV transmission.
2. **Practice safe sex**: Avoid having multiple sex partners, and get tested for HIV and other STIs regularly.
3. **Get tested and treated for STIs**: Many STIs, such as gonorrhea and chlamydia, can increase the risk of HIV transmission. Getting tested and treated for STIs can help prevent HIV.
4. **Use pre-exposure prophylaxis (PrEP)**: PrEP is a daily medication that can help prevent HIV infection in people who are at high risk of exposure.
5. **Use post-exposure prophylaxis (PEP)**: PEP is an emergency medication that can help prevent HIV infection if taken within 72 hours of exposure.
6. **Avoid sharing needles**: Sharing needles or syringes can spread HIV and other bloodborne pathogens. Use sterile needles and syringes, and avoid sharing equipment.
7. **Get vaccinated against hepatitis B**: Hepatitis B and HIV can be transmitted through similar routes, and getting vaccinated against hepatitis B can help reduce the risk of HIV transmission.
8. **Use harm reduction services**: Harm reduction services, such as needle exchange programs and safe injection sites, can help reduce the risk of HIV transmission among people who inject drugs.
9. **Choose a mutually monogamous relationship**: Being in a mutually monogamous relationship with someone who is HIV-negative can reduce the risk of HIV transmission.
10. **Get tested for HIV**: Knowing your HIV status can help you take steps to prevent transmission and get treatment if you are infected.
11. **Use dental dams**: Dental dams can help prevent HIV transmission during oral sex.
12. **Avoid douching**: Douching can increase the risk of HIV transmission by disrupting the natural balance of bacteria in the vagina.
13. **Use lubricants**: Using lubricants can help reduce the risk of condom breakage and HIV transmission.
14. **Get educated**: Learn about HIV transmission, prevention, and treatment to make informed decisions about your health.
15. **Support HIV prevention programs**: Support programs that provide HIV prevention services, such as testing, counseling, and education, to help reduce the spread of HIV.

Remember, HIV prevention is a shared responsibility, and everyone can play a role in reducing the spread of the virus. By taking these steps, you can help protect yourself and others from HIV infection.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): How frequently ART must be taken?
{'role': 'assistant', 'content': "Antiretroviral Therapy (ART) is typically taken daily, and the frequency of taking the medication can vary depending on the specific regimen and the medications prescribed. However, most people living with HIV take their ART medication:\n\n* Once a day (e.g., a single pill or a combination of pills taken at the same time)\n* Twice a day (e.g., morning and evening)\n\nIt's essential to take ART medication as prescribed by your healthcare provider, without missing doses or stopping treatment, to:\n\n1. Maintain viral suppression (keep the virus at very low levels)\n2. Prevent the development of drug resistance\n3. Reduce the risk of transmission to others\n4. Manage symptoms and prevent complications\n\nTaking ART medication consistently and correctly is crucial to achieving and maintaining viral suppression, which is the primary goal of HIV treatment. If you have any concerns or questions about your ART regimen, it's best to consult with your healthcare provider or an HIV specialist."}
Antiretroviral Therapy (ART) is typically taken daily, and the frequency of taking the medication can vary depending on the specific regimen and the medications prescribed. However, most people living with HIV take their ART medication:

* Once a day (e.g., a single pill or a combination of pills taken at the same time)
* Twice a day (e.g., morning and evening)

It's essential to take ART medication as prescribed by your healthcare provider, without missing doses or stopping treatment, to:

1. Maintain viral suppression (keep the virus at very low levels)
2. Prevent the development of drug resistance
3. Reduce the risk of transmission to others
4. Manage symptoms and prevent complications

Taking ART medication consistently and correctly is crucial to achieving and maintaining viral suppression, which is the primary goal of HIV treatment. If you have any concerns or questions about your ART regimen, it's best to consult with your healthcare provider or an HIV specialist.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): How can we prevent Perinatal transmission of HIV?
{'role': 'assistant', 'content': "Preventing perinatal transmission of HIV (also known as mother-to-child transmission) is crucial to reduce the risk of HIV infection in newborns. Here are the effective strategies to prevent perinatal transmission of HIV:\n\n1. **HIV testing and counseling**: All pregnant women should undergo HIV testing and counseling as part of routine prenatal care. This helps identify HIV-positive women and provides an opportunity for interventions to prevent transmission.\n2. **Antiretroviral therapy (ART)**: HIV-positive pregnant women should receive ART to suppress the virus and reduce the risk of transmission to the baby. The goal is to achieve an undetectable viral load, which significantly reduces the risk of transmission.\n3. **Combination ART**: Using a combination of three or more antiretroviral drugs is more effective than using a single drug or a dual therapy regimen.\n4. **Pre-labor cesarean delivery**: For women with a high viral load (above 1000 copies/mL) near the time of delivery, a pre-labor cesarean delivery can reduce the risk of transmission.\n5. **Avoid breastfeeding**: HIV-positive mothers should avoid breastfeeding their babies, as HIV can be transmitted through breast milk. Formula feeding or expressed breast milk from an HIV-negative donor can be used instead.\n6. **Post-exposure prophylaxis (PEP)**: Newborns born to HIV-positive mothers should receive PEP, which typically consists of a 4-6 week course of antiretroviral medication, such as zidovudine (AZT) or nevirapine (NVP).\n7. **Elective cesarean delivery**: For women with a viral load above 1000 copies/mL, an elective cesarean delivery can reduce the risk of transmission.\n8. **Intrapartum antiretroviral prophylaxis**: Administering antiretroviral medication during labor, such as zidovudine (AZT) or nevirapine (NVP), can reduce the risk of transmission.\n9. **Viral load monitoring**: Regular monitoring of the mother's viral load during pregnancy and near the time of delivery can help identify women who may require more intensive interventions.\n10. **Education and support**: Providing education and support to HIV-positive pregnant women and their families can help them understand the importance of adherence to ART and other preventive measures.\n\nBy implementing these strategies, the risk of perinatal transmission of HIV can be significantly reduced, and the number of HIV-positive children can be decreased. According to the World Health Organization (WHO), the implementation of these interventions has led to a significant decline in mother-to-child transmission of HIV, from 15-30% in the 1990s to less than 2% in some countries today."}
Preventing perinatal transmission of HIV (also known as mother-to-child transmission) is crucial to reduce the risk of HIV infection in newborns. Here are the effective strategies to prevent perinatal transmission of HIV:

1. **HIV testing and counseling**: All pregnant women should undergo HIV testing and counseling as part of routine prenatal care. This helps identify HIV-positive women and provides an opportunity for interventions to prevent transmission.
2. **Antiretroviral therapy (ART)**: HIV-positive pregnant women should receive ART to suppress the virus and reduce the risk of transmission to the baby. The goal is to achieve an undetectable viral load, which significantly reduces the risk of transmission.
3. **Combination ART**: Using a combination of three or more antiretroviral drugs is more effective than using a single drug or a dual therapy regimen.
4. **Pre-labor cesarean delivery**: For women with a high viral load (above 1000 copies/mL) near the time of delivery, a pre-labor cesarean delivery can reduce the risk of transmission.
5. **Avoid breastfeeding**: HIV-positive mothers should avoid breastfeeding their babies, as HIV can be transmitted through breast milk. Formula feeding or expressed breast milk from an HIV-negative donor can be used instead.
6. **Post-exposure prophylaxis (PEP)**: Newborns born to HIV-positive mothers should receive PEP, which typically consists of a 4-6 week course of antiretroviral medication, such as zidovudine (AZT) or nevirapine (NVP).
7. **Elective cesarean delivery**: For women with a viral load above 1000 copies/mL, an elective cesarean delivery can reduce the risk of transmission.
8. **Intrapartum antiretroviral prophylaxis**: Administering antiretroviral medication during labor, such as zidovudine (AZT) or nevirapine (NVP), can reduce the risk of transmission.
9. **Viral load monitoring**: Regular monitoring of the mother's viral load during pregnancy and near the time of delivery can help identify women who may require more intensive interventions.
10. **Education and support**: Providing education and support to HIV-positive pregnant women and their families can help them understand the importance of adherence to ART and other preventive measures.

By implementing these strategies, the risk of perinatal transmission of HIV can be significantly reduced, and the number of HIV-positive children can be decreased. According to the World Health Organization (WHO), the implementation of these interventions has led to a significant decline in mother-to-child transmission of HIV, from 15-30% in the 1990s to less than 2% in some countries today.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): What are the main cell types infected with HIV?
{'role': 'assistant', 'content': "The main cell types infected with HIV (Human Immunodeficiency Virus) are:\n\n1. **CD4+ T cells** (also known as T helper cells): These cells play a crucial role in the immune system, helping to coordinate the response to infections. HIV binds to the CD4 receptor on the surface of these cells and enters them, where it replicates and eventually kills the cell.\n2. **Macrophages**: These cells are a type of white blood cell that engulfs and digests foreign particles and microorganisms. Macrophages can also be infected with HIV, which can lead to the production of viral particles and the spread of the infection.\n3. **Dendritic cells**: These cells are antigen-presenting cells that help to activate T cells and initiate an immune response. Dendritic cells can also be infected with HIV, which can facilitate the spread of the virus to other cells.\n\nThese cell types are the primary targets of HIV infection, and the virus's ability to infect and destroy them is a key factor in the development of AIDS (Acquired Immune Deficiency Syndrome)."}
The main cell types infected with HIV (Human Immunodeficiency Virus) are:

1. **CD4+ T cells** (also known as T helper cells): These cells play a crucial role in the immune system, helping to coordinate the response to infections. HIV binds to the CD4 receptor on the surface of these cells and enters them, where it replicates and eventually kills the cell.
2. **Macrophages**: These cells are a type of white blood cell that engulfs and digests foreign particles and microorganisms. Macrophages can also be infected with HIV, which can lead to the production of viral particles and the spread of the infection.
3. **Dendritic cells**: These cells are antigen-presenting cells that help to activate T cells and initiate an immune response. Dendritic cells can also be infected with HIV, which can facilitate the spread of the virus to other cells.

These cell types are the primary targets of HIV infection, and the virus's ability to infect and destroy them is a key factor in the development of AIDS (Acquired Immune Deficiency Syndrome).
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): What is the difference between HIV and AIDS?
{'role': 'assistant', 'content': "HIV (Human Immunodeficiency Virus) and AIDS (Acquired Immune Deficiency Syndrome) are two related but distinct conditions.\n\n**HIV (Human Immunodeficiency Virus):**\n\nHIV is a virus that attacks the body's immune system, specifically the CD4 cells (T cells), which help the immune system fight off infections. When HIV infects these cells, it weakens the immune system, making it harder for the body to fight off opportunistic infections and diseases.\n\nHIV is a chronic and manageable condition, and with proper treatment, people with HIV can live long and healthy lives. HIV is typically transmitted through:\n\n* Unprotected sex with an infected person\n* Sharing needles or syringes with an infected person\n* Mother-to-child transmission during pregnancy, childbirth, or breastfeeding\n* Blood transfusions (although this is rare in developed countries with strict blood screening)\n\n**AIDS (Acquired Immune Deficiency Syndrome):**\n\nAIDS is the most advanced stage of HIV infection. It occurs when the immune system is severely damaged, and the body is unable to fight off opportunistic infections and diseases. AIDS is characterized by:\n\n* A very low CD4 cell count (less than 200 cells per cubic millimeter of blood)\n* The presence of one or more opportunistic infections, such as pneumonia, tuberculosis, or toxoplasmosis\n* The presence of certain types of cancer, such as Kaposi's sarcoma or lymphoma\n\nAIDS is a life-threatening condition that can lead to serious illnesses and death if left untreated. However, with antiretroviral therapy (ART), people with AIDS can manage their condition and prevent the progression of the disease.\n\n**Key differences:**\n\n1. **HIV is a virus, while AIDS is a syndrome**: HIV is the virus that causes the infection, while AIDS is the condition that occurs when the immune system is severely damaged.\n2. **HIV is a chronic condition, while AIDS is a late-stage condition**: HIV can be managed with treatment, while AIDS is a more advanced stage of the disease that requires immediate medical attention.\n3. **HIV can be asymptomatic, while AIDS is often symptomatic**: People with HIV may not show symptoms for years, while people with AIDS often experience severe symptoms, such as weight loss, diarrhea, and opportunistic infections.\n\nIn summary, HIV is a virus that can lead to AIDS, a condition characterized by a severely weakened immune system and the presence of opportunistic infections and diseases. While HIV is a manageable condition, AIDS is a life-threatening condition that requires immediate medical attention."}
HIV (Human Immunodeficiency Virus) and AIDS (Acquired Immune Deficiency Syndrome) are two related but distinct conditions.

**HIV (Human Immunodeficiency Virus):**

HIV is a virus that attacks the body's immune system, specifically the CD4 cells (T cells), which help the immune system fight off infections. When HIV infects these cells, it weakens the immune system, making it harder for the body to fight off opportunistic infections and diseases.

HIV is a chronic and manageable condition, and with proper treatment, people with HIV can live long and healthy lives. HIV is typically transmitted through:

* Unprotected sex with an infected person
* Sharing needles or syringes with an infected person
* Mother-to-child transmission during pregnancy, childbirth, or breastfeeding
* Blood transfusions (although this is rare in developed countries with strict blood screening)

**AIDS (Acquired Immune Deficiency Syndrome):**

AIDS is the most advanced stage of HIV infection. It occurs when the immune system is severely damaged, and the body is unable to fight off opportunistic infections and diseases. AIDS is characterized by:

* A very low CD4 cell count (less than 200 cells per cubic millimeter of blood)
* The presence of one or more opportunistic infections, such as pneumonia, tuberculosis, or toxoplasmosis
* The presence of certain types of cancer, such as Kaposi's sarcoma or lymphoma

AIDS is a life-threatening condition that can lead to serious illnesses and death if left untreated. However, with antiretroviral therapy (ART), people with AIDS can manage their condition and prevent the progression of the disease.

**Key differences:**

1. **HIV is a virus, while AIDS is a syndrome**: HIV is the virus that causes the infection, while AIDS is the condition that occurs when the immune system is severely damaged.
2. **HIV is a chronic condition, while AIDS is a late-stage condition**: HIV can be managed with treatment, while AIDS is a more advanced stage of the disease that requires immediate medical attention.
3. **HIV can be asymptomatic, while AIDS is often symptomatic**: People with HIV may not show symptoms for years, while people with AIDS often experience severe symptoms, such as weight loss, diarrhea, and opportunistic infections.

In summary, HIV is a virus that can lead to AIDS, a condition characterized by a severely weakened immune system and the presence of opportunistic infections and diseases. While HIV is a manageable condition, AIDS is a life-threatening condition that requires immediate medical attention.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): How is HIV not transmitted?
{'role': 'assistant', 'content': "HIV (Human Immunodeficiency Virus) is not transmitted through the following means:\n\n1. **Casual contact**: Shaking hands, hugging, kissing on the cheek, or other casual contact with an infected person does not transmit HIV.\n2. **Air or water**: HIV is not transmitted through the air, water, or food. You cannot get HIV from breathing the same air, drinking from the same water fountain, or eating from the same plate as an infected person.\n3. **Insect bites**: Mosquitoes, ticks, and other insects do not transmit HIV.\n4. **Toilet seats or handles**: HIV does not survive long outside the human body, so you cannot get infected from touching a toilet seat or handle that an infected person has used.\n5. **Sharing food or drinks**: HIV is not transmitted through saliva, so sharing food or drinks with an infected person does not pose a risk.\n6. **Sweat or tears**: HIV is not transmitted through sweat or tears, unless they are mixed with blood or other bodily fluids that contain the virus.\n7. **Coughing or sneezing**: HIV is not transmitted through coughing or sneezing, as the virus is not present in respiratory secretions.\n8. **Touching or handling objects**: You cannot get HIV from touching or handling objects that an infected person has used, such as a phone, keyboard, or other inanimate object.\n9. **Donating blood**: In the United States, all donated blood is screened for HIV, so you cannot get infected from receiving a blood transfusion.\n10. **Vaccinations**: HIV is not transmitted through vaccinations, as the virus is not present in vaccines.\n\nIt's essential to remember that HIV is primarily transmitted through:\n\n* Unprotected sex with an infected person\n* Sharing needles or syringes with an infected person\n* Mother-to-child transmission during pregnancy, childbirth, or breastfeeding (if the mother is not receiving effective treatment)\n\nIf you have concerns about HIV transmission or want to learn more about prevention and testing, consult a healthcare professional or a reputable health organization."}
HIV (Human Immunodeficiency Virus) is not transmitted through the following means:

1. **Casual contact**: Shaking hands, hugging, kissing on the cheek, or other casual contact with an infected person does not transmit HIV.
2. **Air or water**: HIV is not transmitted through the air, water, or food. You cannot get HIV from breathing the same air, drinking from the same water fountain, or eating from the same plate as an infected person.
3. **Insect bites**: Mosquitoes, ticks, and other insects do not transmit HIV.
4. **Toilet seats or handles**: HIV does not survive long outside the human body, so you cannot get infected from touching a toilet seat or handle that an infected person has used.
5. **Sharing food or drinks**: HIV is not transmitted through saliva, so sharing food or drinks with an infected person does not pose a risk.
6. **Sweat or tears**: HIV is not transmitted through sweat or tears, unless they are mixed with blood or other bodily fluids that contain the virus.
7. **Coughing or sneezing**: HIV is not transmitted through coughing or sneezing, as the virus is not present in respiratory secretions.
8. **Touching or handling objects**: You cannot get HIV from touching or handling objects that an infected person has used, such as a phone, keyboard, or other inanimate object.
9. **Donating blood**: In the United States, all donated blood is screened for HIV, so you cannot get infected from receiving a blood transfusion.
10. **Vaccinations**: HIV is not transmitted through vaccinations, as the virus is not present in vaccines.

It's essential to remember that HIV is primarily transmitted through:

* Unprotected sex with an infected person
* Sharing needles or syringes with an infected person
* Mother-to-child transmission during pregnancy, childbirth, or breastfeeding (if the mother is not receiving effective treatment)

If you have concerns about HIV transmission or want to learn more about prevention and testing, consult a healthcare professional or a reputable health organization.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): What is known about the switch that occurs between
{'role': 'assistant', 'content': "The switch from latent HIV to active infection is a complex and not fully understood process. However, research has shed some light on the mechanisms involved. Here's a summary of what is known:\n\n**Latent HIV:**\nLatent HIV refers to a state where the virus is present in the body, but not actively replicating. During latency, the virus integrates into the host genome and remains dormant, often in memory CD4+ T cells. This state is characterized by low or undetectable viral loads, and the virus is not actively producing new virions.\n\n**Reactivation:**\nThe switch from latent to active infection is thought to occur through a series of molecular and cellular events. Some of the key factors involved in reactivation include:\n\n1. **Cellular activation:** Latent HIV-infected cells can be reactivated when they receive activation signals, such as those triggered by inflammation, immune responses, or cellular stress.\n2. **Epigenetic changes:** The latent viral genome is silenced by epigenetic modifications, such as histone methylation and DNA methylation. Reactivation involves the removal of these silencing marks, allowing the viral genome to be transcribed.\n3. **Transcriptional regulation:** The viral genome is regulated by a complex interplay of transcription factors, including the viral protein Tat and host factors like NF-κB and AP-1. Reactivation involves the activation of these transcription factors, which bind to the viral genome and initiate transcription.\n4. **Post-transcriptional regulation:** After transcription, the viral RNA is subject to post-transcriptional regulation, including splicing, polyadenylation, and translation. Reactivation involves the efficient processing and translation of viral RNA into proteins.\n5. **Immune activation:** Reactivation of latent HIV can also be triggered by immune activation, such as during co-infections or vaccinations.\n\n**Triggers for reactivation:**\nSeveral factors can trigger the reactivation of latent HIV, including:\n\n1. **Co-infections:** Infections like tuberculosis, malaria, or other viral infections can reactivate latent HIV.\n2. **Inflammation:** Chronic inflammation, such as that seen in chronic diseases like atherosclerosis or cancer, can reactivate latent HIV.\n3. **Immune activation:** Activation of the immune system, such as during vaccination or immune therapy, can reactivate latent HIV.\n4. **Cellular stress:** Cellular stress, such as that caused by oxidative stress or DNA damage, can reactivate latent HIV.\n5. **Hormonal changes:** Hormonal changes, such as those that occur during pregnancy or menopause, can reactivate latent HIV.\n\n**Consequences of reactivation:**\nThe reactivation of latent HIV can have significant consequences, including:\n\n1. **Viral load increase:** Reactivation can lead to an increase in viral load, which can compromise the immune system and increase the risk of transmission.\n2. **Immune suppression:** Reactivation can also lead to immune suppression, making the individual more susceptible to opportunistic infections and other diseases.\n3. **Disease progression:** Reactivation can contribute to disease progression, including the development of AIDS-defining illnesses.\n\nOverall, the switch from latent to active HIV infection is a complex process involving multiple molecular and cellular events. Understanding the mechanisms involved in reactivation can inform the development of strategies to prevent or delay the onset of active infection, and ultimately improve treatment outcomes for individuals living with HIV."}
The switch from latent HIV to active infection is a complex and not fully understood process. However, research has shed some light on the mechanisms involved. Here's a summary of what is known:

**Latent HIV:**
Latent HIV refers to a state where the virus is present in the body, but not actively replicating. During latency, the virus integrates into the host genome and remains dormant, often in memory CD4+ T cells. This state is characterized by low or undetectable viral loads, and the virus is not actively producing new virions.

**Reactivation:**
The switch from latent to active infection is thought to occur through a series of molecular and cellular events. Some of the key factors involved in reactivation include:

1. **Cellular activation:** Latent HIV-infected cells can be reactivated when they receive activation signals, such as those triggered by inflammation, immune responses, or cellular stress.
2. **Epigenetic changes:** The latent viral genome is silenced by epigenetic modifications, such as histone methylation and DNA methylation. Reactivation involves the removal of these silencing marks, allowing the viral genome to be transcribed.
3. **Transcriptional regulation:** The viral genome is regulated by a complex interplay of transcription factors, including the viral protein Tat and host factors like NF-κB and AP-1. Reactivation involves the activation of these transcription factors, which bind to the viral genome and initiate transcription.
4. **Post-transcriptional regulation:** After transcription, the viral RNA is subject to post-transcriptional regulation, including splicing, polyadenylation, and translation. Reactivation involves the efficient processing and translation of viral RNA into proteins.
5. **Immune activation:** Reactivation of latent HIV can also be triggered by immune activation, such as during co-infections or vaccinations.

**Triggers for reactivation:**
Several factors can trigger the reactivation of latent HIV, including:

1. **Co-infections:** Infections like tuberculosis, malaria, or other viral infections can reactivate latent HIV.
2. **Inflammation:** Chronic inflammation, such as that seen in chronic diseases like atherosclerosis or cancer, can reactivate latent HIV.
3. **Immune activation:** Activation of the immune system, such as during vaccination or immune therapy, can reactivate latent HIV.
4. **Cellular stress:** Cellular stress, such as that caused by oxidative stress or DNA damage, can reactivate latent HIV.
5. **Hormonal changes:** Hormonal changes, such as those that occur during pregnancy or menopause, can reactivate latent HIV.

**Consequences of reactivation:**
The reactivation of latent HIV can have significant consequences, including:

1. **Viral load increase:** Reactivation can lead to an increase in viral load, which can compromise the immune system and increase the risk of transmission.
2. **Immune suppression:** Reactivation can also lead to immune suppression, making the individual more susceptible to opportunistic infections and other diseases.
3. **Disease progression:** Reactivation can contribute to disease progression, including the development of AIDS-defining illnesses.

Overall, the switch from latent to active HIV infection is a complex process involving multiple molecular and cellular events. Understanding the mechanisms involved in reactivation can inform the development of strategies to prevent or delay the onset of active infection, and ultimately improve treatment outcomes for individuals living with HIV.
Saved Llama answers (category=1, iteration=1) to: /cluster/home/gcardenal/HIV/deploy_medical_LLM_evaluation/deploy_medical_llm_evaluation/model_answers/raw/Llama_cluster/Llama_answers_category_1.1_HIV_EQ.json
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): How is HIV diagnosed?
{'role': 'assistant', 'content': "HIV (Human Immunodeficiency Virus) diagnosis typically involves a combination of medical history, physical examination, and laboratory tests. Here's an overview of the diagnostic process:\n\n**Screening Tests:**\n\n1. **Rapid Tests:** These are point-of-care tests that provide quick results, usually within 20-30 minutes. They detect the presence of HIV antibodies in blood or oral fluid.\n2. **Enzyme-Linked Immunosorbent Assay (ELISA):** This is a laboratory-based test that detects HIV antibodies in blood.\n\n**Confirmatory Tests:**\n\n1. **Western Blot:** This test is used to confirm a positive ELISA result. It detects the presence of specific HIV proteins (antigens) in blood.\n2. **Nucleic Acid-Based Tests (NATs):** These tests detect the genetic material (RNA or DNA) of the virus in blood. NATs are used to confirm a positive result, especially in early infection when antibodies may not be present.\n3. **Polymerase Chain Reaction (PCR):** This test is used to detect HIV RNA in blood, which can help confirm a diagnosis and monitor viral load.\n\n**Diagnostic Algorithm:**\n\n1. **Initial Screening:** A rapid test or ELISA is performed to detect HIV antibodies.\n2. **Confirmatory Testing:** If the initial test is positive, a Western Blot or NAT is performed to confirm the diagnosis.\n3. **Viral Load Testing:** If the diagnosis is confirmed, a viral load test (PCR or NAT) is performed to measure the amount of HIV RNA in the blood.\n\n**When to Test:**\n\n1. **After Exposure:** Test 2-4 weeks after a potential exposure to HIV.\n2. **Routine Screening:** Test every 3-6 months if you're at high risk of HIV infection (e.g., multiple sex partners, injection drug use).\n3. **Pregnancy:** Test all pregnant women for HIV as part of routine prenatal care.\n\n**Interpretation of Results:**\n\n1. **Negative Result:** No HIV antibodies or viral RNA are detected.\n2. **Positive Result:** HIV antibodies or viral RNA are detected, indicating HIV infection.\n3. **Indeterminate Result:** The test result is unclear or requires further testing.\n\nIt's essential to note that HIV testing should be performed by a healthcare professional, and results should be interpreted in the context of medical history, physical examination, and other diagnostic tests. If you're concerned about HIV or have questions about testing, consult a healthcare provider or a local health clinic."}
HIV (Human Immunodeficiency Virus) diagnosis typically involves a combination of medical history, physical examination, and laboratory tests. Here's an overview of the diagnostic process:

**Screening Tests:**

1. **Rapid Tests:** These are point-of-care tests that provide quick results, usually within 20-30 minutes. They detect the presence of HIV antibodies in blood or oral fluid.
2. **Enzyme-Linked Immunosorbent Assay (ELISA):** This is a laboratory-based test that detects HIV antibodies in blood.

**Confirmatory Tests:**

1. **Western Blot:** This test is used to confirm a positive ELISA result. It detects the presence of specific HIV proteins (antigens) in blood.
2. **Nucleic Acid-Based Tests (NATs):** These tests detect the genetic material (RNA or DNA) of the virus in blood. NATs are used to confirm a positive result, especially in early infection when antibodies may not be present.
3. **Polymerase Chain Reaction (PCR):** This test is used to detect HIV RNA in blood, which can help confirm a diagnosis and monitor viral load.

**Diagnostic Algorithm:**

1. **Initial Screening:** A rapid test or ELISA is performed to detect HIV antibodies.
2. **Confirmatory Testing:** If the initial test is positive, a Western Blot or NAT is performed to confirm the diagnosis.
3. **Viral Load Testing:** If the diagnosis is confirmed, a viral load test (PCR or NAT) is performed to measure the amount of HIV RNA in the blood.

**When to Test:**

1. **After Exposure:** Test 2-4 weeks after a potential exposure to HIV.
2. **Routine Screening:** Test every 3-6 months if you're at high risk of HIV infection (e.g., multiple sex partners, injection drug use).
3. **Pregnancy:** Test all pregnant women for HIV as part of routine prenatal care.

**Interpretation of Results:**

1. **Negative Result:** No HIV antibodies or viral RNA are detected.
2. **Positive Result:** HIV antibodies or viral RNA are detected, indicating HIV infection.
3. **Indeterminate Result:** The test result is unclear or requires further testing.

It's essential to note that HIV testing should be performed by a healthcare professional, and results should be interpreted in the context of medical history, physical examination, and other diagnostic tests. If you're concerned about HIV or have questions about testing, consult a healthcare provider or a local health clinic.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): What are the different stages of HIV?
{'role': 'assistant', 'content': "HIV (Human Immunodeficiency Virus) infection progresses through several stages, which can vary in duration and severity from person to person. The stages of HIV infection are:\n\n**Stage 1: Acute HIV Infection (0-6 weeks)**\n\n* This is the initial stage of HIV infection, which occurs when the virus first enters the body.\n* During this stage, the virus replicates rapidly, and the person may experience flu-like symptoms, such as fever, headache, and fatigue.\n* The immune system responds to the infection, and the body produces antibodies to fight the virus.\n\n**Stage 2: Clinical Latency (6 weeks to 10-15 years)**\n\n* After the acute stage, the virus enters a latent phase, during which the person may not exhibit any symptoms.\n* The virus continues to replicate, but at a slower rate, and the immune system is able to keep the infection under control.\n* During this stage, the person can still transmit the virus to others, even if they don't show any symptoms.\n\n**Stage 3: Symptomatic HIV Infection (10-15 years or more)**\n\n* As the virus continues to replicate and the immune system weakens, the person may start to experience symptoms, such as:\n\t+ Weight loss\n\t+ Diarrhea\n\t+ Fever\n\t+ Fatigue\n\t+ Swollen lymph nodes\n\t+ Skin rashes\n* The symptoms can be mild or severe and may come and go.\n\n**Stage 4: AIDS (Acquired Immune Deficiency Syndrome)**\n\n* AIDS is the most advanced stage of HIV infection, which occurs when the immune system is severely weakened.\n* At this stage, the person is highly susceptible to opportunistic infections (OIs) and cancers, such as:\n\t+ Pneumocystis pneumonia (PCP)\n\t+ Kaposi's sarcoma\n\t+ Lymphoma\n\t+ Tuberculosis (TB)\n* AIDS is characterized by a CD4 cell count below 200 cells per cubic millimeter of blood (mm³).\n\n**Undetectable Viral Load**\n\n* With effective antiretroviral therapy (ART), it is possible to achieve an undetectable viral load, which means that the virus is no longer detectable in the blood.\n* This stage is not a cure, but it indicates that the treatment is working, and the person is less likely to transmit the virus to others.\n\nIt's essential to note that the progression of HIV infection can be slowed or halted with proper treatment, and many people with HIV can live long and healthy lives with ART. Early diagnosis and treatment are crucial to preventing the progression of the disease and reducing the risk of transmission."}
HIV (Human Immunodeficiency Virus) infection progresses through several stages, which can vary in duration and severity from person to person. The stages of HIV infection are:

**Stage 1: Acute HIV Infection (0-6 weeks)**

* This is the initial stage of HIV infection, which occurs when the virus first enters the body.
* During this stage, the virus replicates rapidly, and the person may experience flu-like symptoms, such as fever, headache, and fatigue.
* The immune system responds to the infection, and the body produces antibodies to fight the virus.

**Stage 2: Clinical Latency (6 weeks to 10-15 years)**

* After the acute stage, the virus enters a latent phase, during which the person may not exhibit any symptoms.
* The virus continues to replicate, but at a slower rate, and the immune system is able to keep the infection under control.
* During this stage, the person can still transmit the virus to others, even if they don't show any symptoms.

**Stage 3: Symptomatic HIV Infection (10-15 years or more)**

* As the virus continues to replicate and the immune system weakens, the person may start to experience symptoms, such as:
	+ Weight loss
	+ Diarrhea
	+ Fever
	+ Fatigue
	+ Swollen lymph nodes
	+ Skin rashes
* The symptoms can be mild or severe and may come and go.

**Stage 4: AIDS (Acquired Immune Deficiency Syndrome)**

* AIDS is the most advanced stage of HIV infection, which occurs when the immune system is severely weakened.
* At this stage, the person is highly susceptible to opportunistic infections (OIs) and cancers, such as:
	+ Pneumocystis pneumonia (PCP)
	+ Kaposi's sarcoma
	+ Lymphoma
	+ Tuberculosis (TB)
* AIDS is characterized by a CD4 cell count below 200 cells per cubic millimeter of blood (mm³).

**Undetectable Viral Load**

* With effective antiretroviral therapy (ART), it is possible to achieve an undetectable viral load, which means that the virus is no longer detectable in the blood.
* This stage is not a cure, but it indicates that the treatment is working, and the person is less likely to transmit the virus to others.

It's essential to note that the progression of HIV infection can be slowed or halted with proper treatment, and many people with HIV can live long and healthy lives with ART. Early diagnosis and treatment are crucial to preventing the progression of the disease and reducing the risk of transmission.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): How is HIV transmitted?
{'role': 'assistant', 'content': "HIV (Human Immunodeficiency Virus) is transmitted through certain bodily fluids from a person who has a detectable viral load and is not taking antiretroviral therapy (ART) or is not virally suppressed. The main ways HIV is transmitted are:\n\n1. **Unprotected sex**: HIV can be transmitted through vaginal, anal, or oral sex without using a condom or other barrier method. The risk is higher for anal sex and lower for oral sex.\n2. **Sharing needles or syringes**: Sharing needles or syringes to inject drugs can transmit HIV if the equipment is contaminated with infected blood.\n3. **Mother-to-child transmission**: HIV can be transmitted from an infected mother to her child during pregnancy, childbirth, or breastfeeding. However, this can be prevented with proper medical care and treatment.\n4. **Blood transfusions**: In rare cases, HIV can be transmitted through blood transfusions if the blood is not properly screened for the virus.\n5. **Occupational exposure**: Healthcare workers may be at risk of HIV transmission if they are exposed to infected blood or other bodily fluids through needlesticks or other accidents.\n\nIt's essential to note that HIV is **not** transmitted through:\n\n* Casual contact, such as shaking hands, hugging, or sharing food and drinks\n* Air or water\n* Insect bites\n* Saliva, sweat, or tears, unless they are mixed with blood\n* Toilet seats, doorknobs, or other surfaces\n\nTo prevent HIV transmission, it's crucial to:\n\n* Use condoms or other barrier methods during sex\n* Get tested regularly for HIV and other STIs\n* Avoid sharing needles or syringes\n* Take antiretroviral therapy (ART) if you are living with HIV to suppress the virus and prevent transmission to others\n* Follow safe injection practices if you use drugs\n* Consider pre-exposure prophylaxis (PrEP) if you are at high risk of HIV transmission\n\nRemember, HIV is a preventable disease, and knowledge is power. If you have any concerns or questions, consult a healthcare professional or a trusted resource."}
HIV (Human Immunodeficiency Virus) is transmitted through certain bodily fluids from a person who has a detectable viral load and is not taking antiretroviral therapy (ART) or is not virally suppressed. The main ways HIV is transmitted are:

1. **Unprotected sex**: HIV can be transmitted through vaginal, anal, or oral sex without using a condom or other barrier method. The risk is higher for anal sex and lower for oral sex.
2. **Sharing needles or syringes**: Sharing needles or syringes to inject drugs can transmit HIV if the equipment is contaminated with infected blood.
3. **Mother-to-child transmission**: HIV can be transmitted from an infected mother to her child during pregnancy, childbirth, or breastfeeding. However, this can be prevented with proper medical care and treatment.
4. **Blood transfusions**: In rare cases, HIV can be transmitted through blood transfusions if the blood is not properly screened for the virus.
5. **Occupational exposure**: Healthcare workers may be at risk of HIV transmission if they are exposed to infected blood or other bodily fluids through needlesticks or other accidents.

It's essential to note that HIV is **not** transmitted through:

* Casual contact, such as shaking hands, hugging, or sharing food and drinks
* Air or water
* Insect bites
* Saliva, sweat, or tears, unless they are mixed with blood
* Toilet seats, doorknobs, or other surfaces

To prevent HIV transmission, it's crucial to:

* Use condoms or other barrier methods during sex
* Get tested regularly for HIV and other STIs
* Avoid sharing needles or syringes
* Take antiretroviral therapy (ART) if you are living with HIV to suppress the virus and prevent transmission to others
* Follow safe injection practices if you use drugs
* Consider pre-exposure prophylaxis (PrEP) if you are at high risk of HIV transmission

Remember, HIV is a preventable disease, and knowledge is power. If you have any concerns or questions, consult a healthcare professional or a trusted resource.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): What comorbidities are common among people living 
{'role': 'assistant', 'content': "People living with HIV (PLWH) are at increased risk of developing various comorbidities, which can be attributed to the chronic inflammation and immune activation caused by the virus, as well as the side effects of antiretroviral therapy (ART). Some common comorbidities among PLWH include:\n\n1. **Cardiovascular disease**: PLWH are at higher risk of developing cardiovascular disease, including heart attacks, strokes, and peripheral artery disease, due to increased inflammation and lipid abnormalities.\n2. **Hepatitis B and C co-infection**: PLWH are more likely to be co-infected with hepatitis B and C, which can lead to liver disease, cirrhosis, and liver cancer.\n3. **Mental health disorders**: Depression, anxiety, and other mental health disorders are common among PLWH, often related to the stress of living with a chronic illness, stigma, and social isolation.\n4. **Substance use disorders**: PLWH are more likely to experience substance use disorders, including addiction to opioids, cocaine, and other substances, which can worsen HIV-related health outcomes.\n5. **Tuberculosis (TB)**: PLWH are at increased risk of developing TB, particularly in resource-limited settings, due to their compromised immune system.\n6. **Cancer**: PLWH are at higher risk of developing certain types of cancer, including:\n\t* Kaposi's sarcoma\n\t* Non-Hodgkin lymphoma\n\t* Cervical cancer\n\t* Anal cancer\n\t* Liver cancer\n7. **Osteoporosis**: PLWH are at increased risk of osteoporosis, particularly those with advanced HIV disease or those taking certain ART medications.\n8. **Kidney disease**: PLWH are at higher risk of developing kidney disease, including HIV-associated nephropathy (HIVAN) and other forms of kidney damage.\n9. **Neurological disorders**: PLWH are at increased risk of developing neurological disorders, including:\n\t* HIV-associated neurocognitive disorder (HAND)\n\t* Peripheral neuropathy\n\t* Seizure disorders\n10. **Gastrointestinal disorders**: PLWH are at higher risk of developing gastrointestinal disorders, including:\n\t* Diarrhea\n\t* Gastroesophageal reflux disease (GERD)\n\t* Inflammatory bowel disease (IBD)\n11. **Endocrine disorders**: PLWH are at increased risk of developing endocrine disorders, including:\n\t* Diabetes mellitus\n\t* Lipodystrophy (abnormal fat distribution)\n\t* Thyroid dysfunction\n12. **Respiratory diseases**: PLWH are at higher risk of developing respiratory diseases, including:\n\t* Chronic obstructive pulmonary disease (COPD)\n\t* Pneumonia\n\t* Tuberculosis (TB)\n\nThese comorbidities can significantly impact the quality of life and life expectancy of PLWH, highlighting the importance of comprehensive care and management of HIV and related comorbidities."}
People living with HIV (PLWH) are at increased risk of developing various comorbidities, which can be attributed to the chronic inflammation and immune activation caused by the virus, as well as the side effects of antiretroviral therapy (ART). Some common comorbidities among PLWH include:

1. **Cardiovascular disease**: PLWH are at higher risk of developing cardiovascular disease, including heart attacks, strokes, and peripheral artery disease, due to increased inflammation and lipid abnormalities.
2. **Hepatitis B and C co-infection**: PLWH are more likely to be co-infected with hepatitis B and C, which can lead to liver disease, cirrhosis, and liver cancer.
3. **Mental health disorders**: Depression, anxiety, and other mental health disorders are common among PLWH, often related to the stress of living with a chronic illness, stigma, and social isolation.
4. **Substance use disorders**: PLWH are more likely to experience substance use disorders, including addiction to opioids, cocaine, and other substances, which can worsen HIV-related health outcomes.
5. **Tuberculosis (TB)**: PLWH are at increased risk of developing TB, particularly in resource-limited settings, due to their compromised immune system.
6. **Cancer**: PLWH are at higher risk of developing certain types of cancer, including:
	* Kaposi's sarcoma
	* Non-Hodgkin lymphoma
	* Cervical cancer
	* Anal cancer
	* Liver cancer
7. **Osteoporosis**: PLWH are at increased risk of osteoporosis, particularly those with advanced HIV disease or those taking certain ART medications.
8. **Kidney disease**: PLWH are at higher risk of developing kidney disease, including HIV-associated nephropathy (HIVAN) and other forms of kidney damage.
9. **Neurological disorders**: PLWH are at increased risk of developing neurological disorders, including:
	* HIV-associated neurocognitive disorder (HAND)
	* Peripheral neuropathy
	* Seizure disorders
10. **Gastrointestinal disorders**: PLWH are at higher risk of developing gastrointestinal disorders, including:
	* Diarrhea
	* Gastroesophageal reflux disease (GERD)
	* Inflammatory bowel disease (IBD)
11. **Endocrine disorders**: PLWH are at increased risk of developing endocrine disorders, including:
	* Diabetes mellitus
	* Lipodystrophy (abnormal fat distribution)
	* Thyroid dysfunction
12. **Respiratory diseases**: PLWH are at higher risk of developing respiratory diseases, including:
	* Chronic obstructive pulmonary disease (COPD)
	* Pneumonia
	* Tuberculosis (TB)

These comorbidities can significantly impact the quality of life and life expectancy of PLWH, highlighting the importance of comprehensive care and management of HIV and related comorbidities.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): How can HIV be prevented?
{'role': 'assistant', 'content': "HIV (Human Immunodeficiency Virus) can be prevented through a combination of strategies that reduce the risk of transmission. Here are some effective ways to prevent HIV:\n\n1. **Use condoms**: Consistent and correct use of condoms during vaginal, anal, and oral sex can significantly reduce the risk of HIV transmission.\n2. **Practice abstinence**: Abstaining from sex or delaying the onset of sexual activity can prevent HIV transmission.\n3. **Get tested**: Regular HIV testing can help identify individuals who are infected, allowing them to receive treatment and prevent transmission to others.\n4. **Use pre-exposure prophylaxis (PrEP)**: PrEP is a medication taken by individuals who are at high risk of HIV infection to prevent transmission. It is highly effective when taken consistently.\n5. **Use post-exposure prophylaxis (PEP)**: PEP is an emergency medication taken after potential exposure to HIV to prevent infection. It must be started within 72 hours of exposure.\n6. **Avoid sharing needles**: Sharing needles or syringes can transmit HIV and other blood-borne pathogens. Use sterile needles and syringes, and participate in needle exchange programs if available.\n7. **Get vaccinated**: While there is no vaccine to prevent HIV, vaccines are available to prevent other sexually transmitted infections (STIs) that can increase the risk of HIV transmission, such as hepatitis B and human papillomavirus (HPV).\n8. **Reduce the number of sexual partners**: Having fewer sexual partners can reduce the risk of HIV transmission.\n9. **Choose low-risk sexual activities**: Engaging in low-risk sexual activities, such as oral sex with a condom, can reduce the risk of HIV transmission.\n10. **Seek medical care**: If you are HIV-positive, receiving antiretroviral therapy (ART) can suppress the virus, reducing the risk of transmission to others.\n11. **Use HIV self-testing**: HIV self-testing kits can help individuals detect HIV infection and seek medical care and treatment.\n12. **Participate in harm reduction programs**: Harm reduction programs, such as needle exchange programs and methadone maintenance therapy, can help reduce the risk of HIV transmission among individuals who inject drugs.\n\nIt's essential to remember that no single method is 100% effective, and a combination of these strategies can provide the best protection against HIV transmission.\n\n**Additional resources:**\n\n* Centers for Disease Control and Prevention (CDC): [www.cdc.gov/hiv](http://www.cdc.gov/hiv)\n* World Health Organization (WHO): [www.who.int/hiv](http://www.who.int/hiv)\n* AIDS.gov: [www.aids.gov](http://www.aids.gov)\n\nRemember, prevention is key, and taking proactive steps can significantly reduce the risk of HIV transmission."}
HIV (Human Immunodeficiency Virus) can be prevented through a combination of strategies that reduce the risk of transmission. Here are some effective ways to prevent HIV:

1. **Use condoms**: Consistent and correct use of condoms during vaginal, anal, and oral sex can significantly reduce the risk of HIV transmission.
2. **Practice abstinence**: Abstaining from sex or delaying the onset of sexual activity can prevent HIV transmission.
3. **Get tested**: Regular HIV testing can help identify individuals who are infected, allowing them to receive treatment and prevent transmission to others.
4. **Use pre-exposure prophylaxis (PrEP)**: PrEP is a medication taken by individuals who are at high risk of HIV infection to prevent transmission. It is highly effective when taken consistently.
5. **Use post-exposure prophylaxis (PEP)**: PEP is an emergency medication taken after potential exposure to HIV to prevent infection. It must be started within 72 hours of exposure.
6. **Avoid sharing needles**: Sharing needles or syringes can transmit HIV and other blood-borne pathogens. Use sterile needles and syringes, and participate in needle exchange programs if available.
7. **Get vaccinated**: While there is no vaccine to prevent HIV, vaccines are available to prevent other sexually transmitted infections (STIs) that can increase the risk of HIV transmission, such as hepatitis B and human papillomavirus (HPV).
8. **Reduce the number of sexual partners**: Having fewer sexual partners can reduce the risk of HIV transmission.
9. **Choose low-risk sexual activities**: Engaging in low-risk sexual activities, such as oral sex with a condom, can reduce the risk of HIV transmission.
10. **Seek medical care**: If you are HIV-positive, receiving antiretroviral therapy (ART) can suppress the virus, reducing the risk of transmission to others.
11. **Use HIV self-testing**: HIV self-testing kits can help individuals detect HIV infection and seek medical care and treatment.
12. **Participate in harm reduction programs**: Harm reduction programs, such as needle exchange programs and methadone maintenance therapy, can help reduce the risk of HIV transmission among individuals who inject drugs.

It's essential to remember that no single method is 100% effective, and a combination of these strategies can provide the best protection against HIV transmission.

**Additional resources:**

* Centers for Disease Control and Prevention (CDC): [www.cdc.gov/hiv](http://www.cdc.gov/hiv)
* World Health Organization (WHO): [www.who.int/hiv](http://www.who.int/hiv)
* AIDS.gov: [www.aids.gov](http://www.aids.gov)

Remember, prevention is key, and taking proactive steps can significantly reduce the risk of HIV transmission.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): How frequently ART must be taken?
{'role': 'assistant', 'content': "Antiretroviral Therapy (ART) is typically taken daily, and the frequency of taking the medication depends on the specific regimen prescribed by a healthcare provider. Most ART regimens involve taking medication once or twice a day, with or without food, at the same time every day.\n\nIt's essential to take ART as directed by a healthcare provider to:\n\n1. Maintain an undetectable viral load\n2. Prevent the development of drug resistance\n3. Keep the immune system strong\n4. Reduce the risk of transmission to others\n\nCommon ART regimens may include:\n\n* Once-daily regimens: Take all medications at the same time, once a day\n* Twice-daily regimens: Take some medications in the morning and others at night, or take all medications twice a day\n* Combination regimens: Take multiple medications at the same time, with or without food\n\nIt's crucial to adhere to the prescribed regimen and take ART consistently to achieve optimal treatment outcomes. Missing doses or taking medication irregularly can lead to:\n\n* Reduced effectiveness of the treatment\n* Increased risk of drug resistance\n* Worsening of HIV-related symptoms\n* Increased risk of transmission to others\n\nIf you're taking ART, it's essential to:\n\n* Set reminders to take your medication at the same time every day\n* Keep a medication calendar or log to track your doses\n* Inform your healthcare provider if you miss a dose or experience any side effects\n* Attend regular follow-up appointments to monitor your treatment progress and adjust your regimen as needed."}
Antiretroviral Therapy (ART) is typically taken daily, and the frequency of taking the medication depends on the specific regimen prescribed by a healthcare provider. Most ART regimens involve taking medication once or twice a day, with or without food, at the same time every day.

It's essential to take ART as directed by a healthcare provider to:

1. Maintain an undetectable viral load
2. Prevent the development of drug resistance
3. Keep the immune system strong
4. Reduce the risk of transmission to others

Common ART regimens may include:

* Once-daily regimens: Take all medications at the same time, once a day
* Twice-daily regimens: Take some medications in the morning and others at night, or take all medications twice a day
* Combination regimens: Take multiple medications at the same time, with or without food

It's crucial to adhere to the prescribed regimen and take ART consistently to achieve optimal treatment outcomes. Missing doses or taking medication irregularly can lead to:

* Reduced effectiveness of the treatment
* Increased risk of drug resistance
* Worsening of HIV-related symptoms
* Increased risk of transmission to others

If you're taking ART, it's essential to:

* Set reminders to take your medication at the same time every day
* Keep a medication calendar or log to track your doses
* Inform your healthcare provider if you miss a dose or experience any side effects
* Attend regular follow-up appointments to monitor your treatment progress and adjust your regimen as needed.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): How can we prevent Perinatal transmission of HIV?
{'role': 'assistant', 'content': "Preventing perinatal transmission of HIV (also known as mother-to-child transmission) is crucial to reduce the risk of HIV infection in newborns. Here are the ways to prevent perinatal transmission of HIV:\n\n1. **HIV testing and counseling**: All pregnant women should undergo HIV testing and counseling as part of their prenatal care. This helps identify HIV-positive women and provides an opportunity for intervention.\n2. **Antiretroviral therapy (ART)**: HIV-positive pregnant women should receive ART to reduce their viral load and prevent transmission to their baby. ART should be started as soon as possible, ideally before 14 weeks of gestation.\n3. **Combination antiretroviral therapy**: Using a combination of antiretroviral medications is more effective in preventing transmission than using a single medication.\n4. **Viral load monitoring**: Regular monitoring of the mother's viral load helps adjust the treatment regimen and minimize the risk of transmission.\n5. **Elective cesarean delivery**: For women with high viral loads (>1000 copies/mL) near the time of delivery, elective cesarean delivery can reduce the risk of transmission.\n6. **Avoidance of breastfeeding**: HIV-positive mothers should avoid breastfeeding their babies, as HIV can be transmitted through breast milk.\n7. **Post-exposure prophylaxis (PEP)**: Newborns born to HIV-positive mothers should receive PEP, which typically consists of a 4-6 week course of antiretroviral medication, to reduce the risk of transmission.\n8. **Pre-labor rupture of membranes management**: If the mother's water breaks before labor, the healthcare provider should manage the situation to minimize the risk of transmission.\n9. **Intrapartum antiretroviral therapy**: Administering antiretroviral medication during labor can help reduce the risk of transmission.\n10. **Follow-up care**: After delivery, the mother and baby should receive regular follow-up care, including HIV testing and monitoring, to ensure the baby's health and adjust treatment as needed.\n\nBy following these guidelines, the risk of perinatal transmission of HIV can be significantly reduced, and the number of children born with HIV can be decreased.\n\n**Current statistics:**\n\n* With proper treatment and care, the risk of perinatal transmission of HIV can be reduced to less than 1%.\n* In the United States, the rate of perinatal HIV transmission has decreased by over 90% since the early 1990s.\n* Globally, the number of children newly infected with HIV has decreased by 35% since 2010.\n\n**References:**\n\n* World Health Organization (WHO). (2020). Prevention of mother-to-child transmission of HIV.\n* Centers for Disease Control and Prevention (CDC). (2020). Preventing Mother-to-Child Transmission of HIV.\n* American College of Obstetricians and Gynecologists (ACOG). (2020). HIV and Pregnancy."}
Preventing perinatal transmission of HIV (also known as mother-to-child transmission) is crucial to reduce the risk of HIV infection in newborns. Here are the ways to prevent perinatal transmission of HIV:

1. **HIV testing and counseling**: All pregnant women should undergo HIV testing and counseling as part of their prenatal care. This helps identify HIV-positive women and provides an opportunity for intervention.
2. **Antiretroviral therapy (ART)**: HIV-positive pregnant women should receive ART to reduce their viral load and prevent transmission to their baby. ART should be started as soon as possible, ideally before 14 weeks of gestation.
3. **Combination antiretroviral therapy**: Using a combination of antiretroviral medications is more effective in preventing transmission than using a single medication.
4. **Viral load monitoring**: Regular monitoring of the mother's viral load helps adjust the treatment regimen and minimize the risk of transmission.
5. **Elective cesarean delivery**: For women with high viral loads (>1000 copies/mL) near the time of delivery, elective cesarean delivery can reduce the risk of transmission.
6. **Avoidance of breastfeeding**: HIV-positive mothers should avoid breastfeeding their babies, as HIV can be transmitted through breast milk.
7. **Post-exposure prophylaxis (PEP)**: Newborns born to HIV-positive mothers should receive PEP, which typically consists of a 4-6 week course of antiretroviral medication, to reduce the risk of transmission.
8. **Pre-labor rupture of membranes management**: If the mother's water breaks before labor, the healthcare provider should manage the situation to minimize the risk of transmission.
9. **Intrapartum antiretroviral therapy**: Administering antiretroviral medication during labor can help reduce the risk of transmission.
10. **Follow-up care**: After delivery, the mother and baby should receive regular follow-up care, including HIV testing and monitoring, to ensure the baby's health and adjust treatment as needed.

By following these guidelines, the risk of perinatal transmission of HIV can be significantly reduced, and the number of children born with HIV can be decreased.

**Current statistics:**

* With proper treatment and care, the risk of perinatal transmission of HIV can be reduced to less than 1%.
* In the United States, the rate of perinatal HIV transmission has decreased by over 90% since the early 1990s.
* Globally, the number of children newly infected with HIV has decreased by 35% since 2010.

**References:**

* World Health Organization (WHO). (2020). Prevention of mother-to-child transmission of HIV.
* Centers for Disease Control and Prevention (CDC). (2020). Preventing Mother-to-Child Transmission of HIV.
* American College of Obstetricians and Gynecologists (ACOG). (2020). HIV and Pregnancy.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): What are the main cell types infected with HIV?
{'role': 'assistant', 'content': "The main cell types infected with HIV (Human Immunodeficiency Virus) are:\n\n1. **CD4+ T cells** (also known as T helper cells): These cells play a crucial role in the immune system, helping to coordinate the response to infections. HIV infects and destroys CD4+ T cells, which can lead to a weakened immune system.\n2. **Macrophages**: These cells are a type of white blood cell that engulfs and digests foreign particles and microorganisms. Macrophages can be infected with HIV, which can lead to the production of new virus particles.\n3. **Dendritic cells**: These cells are antigen-presenting cells that help to activate T cells and initiate an immune response. Dendritic cells can be infected with HIV, which can facilitate the transmission of the virus to other cells.\n\nThese cell types are the primary targets of HIV infection, and the virus uses various mechanisms to enter and replicate within them. The infection of these cells can lead to a range of immunological and pathological consequences, including immune suppression, inflammation, and tissue damage.\n\nIt's worth noting that HIV can also infect other cell types, such as:\n\n* **Lymphoid cells** (e.g., B cells, natural killer cells)\n* **Monocytes**\n* **Microglial cells** (in the brain)\n* **Follicular dendritic cells** (in lymphoid tissues)\n\nHowever, CD4+ T cells, macrophages, and dendritic cells are the primary cell types targeted by HIV."}
The main cell types infected with HIV (Human Immunodeficiency Virus) are:

1. **CD4+ T cells** (also known as T helper cells): These cells play a crucial role in the immune system, helping to coordinate the response to infections. HIV infects and destroys CD4+ T cells, which can lead to a weakened immune system.
2. **Macrophages**: These cells are a type of white blood cell that engulfs and digests foreign particles and microorganisms. Macrophages can be infected with HIV, which can lead to the production of new virus particles.
3. **Dendritic cells**: These cells are antigen-presenting cells that help to activate T cells and initiate an immune response. Dendritic cells can be infected with HIV, which can facilitate the transmission of the virus to other cells.

These cell types are the primary targets of HIV infection, and the virus uses various mechanisms to enter and replicate within them. The infection of these cells can lead to a range of immunological and pathological consequences, including immune suppression, inflammation, and tissue damage.

It's worth noting that HIV can also infect other cell types, such as:

* **Lymphoid cells** (e.g., B cells, natural killer cells)
* **Monocytes**
* **Microglial cells** (in the brain)
* **Follicular dendritic cells** (in lymphoid tissues)

However, CD4+ T cells, macrophages, and dendritic cells are the primary cell types targeted by HIV.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): What is the difference between HIV and AIDS?
{'role': 'assistant', 'content': "HIV (Human Immunodeficiency Virus) and AIDS (Acquired Immune Deficiency Syndrome) are two related but distinct conditions.\n\n**HIV (Human Immunodeficiency Virus)**\n\nHIV is a viral infection that attacks the body's immune system, specifically the CD4 cells (also known as T cells), which help the immune system fight off infections. When HIV infects a person, it weakens their immune system, making them more susceptible to illnesses and infections.\n\nHIV is a chronic condition, meaning it can be managed with treatment, but it is not curable. If left untreated, HIV can progress to AIDS.\n\n**AIDS (Acquired Immune Deficiency Syndrome)**\n\nAIDS is the most advanced stage of HIV infection. It occurs when the immune system is severely damaged, and the body is unable to fight off opportunistic infections and diseases.\n\nAIDS is characterized by:\n\n1. A very low CD4 cell count (less than 200 cells per cubic millimeter of blood).\n2. The presence of one or more opportunistic infections, such as pneumonia, tuberculosis, or toxoplasmosis.\n3. The presence of certain types of cancer, such as Kaposi's sarcoma or lymphoma.\n\nAIDS is a life-threatening condition, and without treatment, it can lead to death.\n\n**Key differences**\n\n1. **Timeframe**: HIV is a long-term condition that can take years to progress to AIDS, while AIDS is the final stage of HIV infection.\n2. **Immune system damage**: HIV damages the immune system, while AIDS is characterized by severe immune system damage.\n3. **Symptoms**: HIV may not have noticeable symptoms, while AIDS is characterized by severe symptoms, such as weight loss, diarrhea, and opportunistic infections.\n4. **Treatment**: HIV can be managed with antiretroviral therapy (ART), while AIDS requires more aggressive treatment, including ART and treatment for opportunistic infections.\n\nIn summary, HIV is a viral infection that can lead to AIDS, which is the most advanced stage of HIV infection, characterized by severe immune system damage and life-threatening opportunistic infections."}
HIV (Human Immunodeficiency Virus) and AIDS (Acquired Immune Deficiency Syndrome) are two related but distinct conditions.

**HIV (Human Immunodeficiency Virus)**

HIV is a viral infection that attacks the body's immune system, specifically the CD4 cells (also known as T cells), which help the immune system fight off infections. When HIV infects a person, it weakens their immune system, making them more susceptible to illnesses and infections.

HIV is a chronic condition, meaning it can be managed with treatment, but it is not curable. If left untreated, HIV can progress to AIDS.

**AIDS (Acquired Immune Deficiency Syndrome)**

AIDS is the most advanced stage of HIV infection. It occurs when the immune system is severely damaged, and the body is unable to fight off opportunistic infections and diseases.

AIDS is characterized by:

1. A very low CD4 cell count (less than 200 cells per cubic millimeter of blood).
2. The presence of one or more opportunistic infections, such as pneumonia, tuberculosis, or toxoplasmosis.
3. The presence of certain types of cancer, such as Kaposi's sarcoma or lymphoma.

AIDS is a life-threatening condition, and without treatment, it can lead to death.

**Key differences**

1. **Timeframe**: HIV is a long-term condition that can take years to progress to AIDS, while AIDS is the final stage of HIV infection.
2. **Immune system damage**: HIV damages the immune system, while AIDS is characterized by severe immune system damage.
3. **Symptoms**: HIV may not have noticeable symptoms, while AIDS is characterized by severe symptoms, such as weight loss, diarrhea, and opportunistic infections.
4. **Treatment**: HIV can be managed with antiretroviral therapy (ART), while AIDS requires more aggressive treatment, including ART and treatment for opportunistic infections.

In summary, HIV is a viral infection that can lead to AIDS, which is the most advanced stage of HIV infection, characterized by severe immune system damage and life-threatening opportunistic infections.
API call for Llama failed with error: Connection error.
Starting inference for question locally (Llama): How is HIV not transmitted?
srun: Job step aborted: Waiting up to 32 seconds for job step to finish.
slurmstepd: error: *** STEP 20835073.0 ON eu-a65-05 CANCELLED AT 2025-01-15T11:07:14 ***
slurmstepd: error: *** JOB 20835073 ON eu-a65-05 CANCELLED AT 2025-01-15T11:07:14 ***
W0115 11:07:14.339000 23290779203392 torch/distributed/elastic/agent/server/api.py:741] Received 15 death signal, shutting down workers
W0115 11:07:14.340000 23290779203392 torch/distributed/elastic/multiprocessing/api.py:851] Sending process 4030286 closing signal SIGTERM
